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1 Summary 
1 Summary 
IgG are heterotetrameric proteins with two identical heavy (H) and two identical light (L) chain, 
which are now one of the largest categories of biopharmaceutical products in development. 
Mammalian cells are the dominant system for the production of recombinant proteins for clinical 
applications. The volumetric productivity of mammalian cells cultivated in bioreactors increased 
significantly over the past 20 years because of improvements in media composition and process 
control. However, there are only few ideas to predict what kind of vector design is optimal for 
stable or transient production of recombinant IgG. In this study, a series of mammalian 
expression vectors for the production of recombinant human or chimeric IgG antibodies with 
different expression cassette designs were constructed. The impact of promoters, the effects of 
the ratio of heavy chain to light chain for efficient IgG folding and assembly, the difference 
between monocistronic and policistronic mammalian expression as well as the impact of 
bicistronic expression vector on the stability of long term recombinant IgG expression were 
systematically analyzed.  
The impact of cistron arrangement of H and L chain in polycistronic vectors was firstly evaluated 
in transfected cells using yellow fluorescence protein as reporter. No apparent affection was 
detected from the cistron arrangements of H and L chain in transiently transfected HEK 293T 
cells. However, in stably transfected CHO-K1 cells, the downstream cistron of H chain exerted 
more negative affection to cap-dependent translation of upstream cistron than L chain did.  
Promoters effect IgG expression levels significantly in transiently transfected cells, the EF1-α 
promoter was more efficient than the human CMV-IE promoter for recombinant IgG expression. 
The Encephalomyocarditis virus (EMCV) IRES mediated bicistronic expression constructs 
could yield IgG expression levels in the same range as monocistronic expression in transiently 
transfected cells, and it could keep long-term stability in CHO-K1 cell lines.  
To investigate the optimal range of the H and L chain intracellular expression levels for IgG 
folding and assembly, a series of EMCV IRES variants with different translation efficiencies was 
used to mediate H chain translation in the bicistronic setup L-IRES-H with IgG L chain as first 
cistron. It provides a novel method for the investigation of oligomeric protein mammalian 
expression. It seems that the optimal expression level was obtained when the IRES mediated 
translation efficiency was about 0,5 compared to cap-dependent translation.  
To enhance the stability of IgG expression in stably transfected CHO cells, a 2,2 Kb 
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scaffold/matrix attached region (S/MAR) from human beta-interferon gene was used to modify 
the bicistronic IgG expression plasmid. It was shown that the S/MAR could apparently increase 
the prevalence of positive clones when it was placed flanking the bicistronic expression cassette. 
The effect on the expression levels from single clones needs to be studied further.  
Finally, a human anti-MUC1 scFv was transformed into IgG and produced in CHO cells. 
Expression levels were evaluated in transiently and stably transfected cells.  
 2
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2 Introduction 
2.1 Immunoglobulins 
Immunoglobulins are heterotetrameric proteins with two identical heavy (H) and two identical light 
(L) polypeptide chains. H chains are of five different classes: µ, γ, δ, α, or ε, with four subclasses 
of γ and two of α in humans. The L chains come with two different constant regions, κ and λ. In 
humans, there is one κ gene and four highly similar functional λ genes. 
Table 1 Immunoglobulin type and structure 
Type IgM IgD IgG IgA IgE 
H Chain µ δ γ α ε 
Structure (µ2L+2)5J# δ2L2 γ2L2 (α2L2)2J ε2L2
+ Light chain is composed of κ and λ subclass. #J is a joining protein in IgM and IgA. All other Igs 
exist as tetramer.  
The ratio of the two types of L chains present in the serum varies from species to species. In mice, 
the κ:λ ratio is 20:1, in human it is 2:1 and in cattle it is 1:20. Each chain folds into globular, β 
barrel structures. The isotype of the L chain can influence the kinetics of Ig intracellular folding 
and assembly (Montano and Morrison 2002). The type and function of immunoglobulins are 
determined by the heavy chain (Tab 1). IgM is the first Ig to be made by the fetus and the first Ig to 
be made by a B cells when it is stimulated by antigen, and is the third most common serum Ig. 
IgM normally exists as a pentamer but it can also exist as a monomer. IgA is the second most 
common serum Ig and is the major class of Ig in secretions - tears, saliva, colostrum, mucus. 
Serum IgA is a monomer but IgA found in secretions is a dimer. IgD is found in low levels in serum 
and its role in serum is uncertain. IgD exists only as a monomer. IgE is the least common serum 
Ig, it binds very tightly to Fc receptors on basophils and mast cells even before interacting with 
antigen, which is involved in allergic reactions. IgE exists as a monomer and has an extra domain 
in the constant region. The IgG class is the predominant antibody isotype in the blood and 
interstitial fluids, which is composed of 4 subclasses, IgG1, IgG2, IgG3 and IgG4. IgG posses the 
central ability to activate complement, binding to effector cells, which leads to destruction of 
invading cells, but not all subclasses work equally well. IgG4 does not fix complement, and IgG2 
and IgG4 do not bind to Fc receptors. All IgG's are monomers of heterotetrameric proteins; the 
main differences between each subclass are the number of disulfide bonds and length of the 
hinge region (Fig. 1). The IgG molecule is divided into three functional domains, two 
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antigen-binding (Fab) regions with identical antigen specificity connected by a highly flexible 
hinge region to the Fc (effector) portion (Fig. 2). The antigen-binding regions of the Ab are located 
at the "upper" tips of the Y-shaped IgG molecule. Each binding site of the IgG is composed of the 
two variable regions of the heavy and light chain, which include 6 hypervariable loops (CDRs). 
These CDR-loops create most of the antigen-binding surface of the molecule. The effector 
functions of IgG such as activation of the complement cascade, induction of immune 
phagocytosis and Ab-dependent cell cytotoxicity are mediated by the Fc portion of the molecule. 
Within the Fc, many of the structural motifs responsible for the recognition of effector elements 
have been identified.  
 
Figure 1 Schematic drawings of IgG subclasses. (The drawing was originally designed by 
Mike Clark) 
2.2 Recombinant antibodies 
One of the main obstacles to effective antibody therapy is the immunogenicity of xenogeneic 
antibodies. The genetic engineering technology opened a new era for the generation of 
antibodies, which makes it possible to isolate fully human antibodies. Many different methods 
have been developed for the selection of antigen binding Ab fragments scFv or Fab (Fig. 2), 
including phage, yeast, bacterial or ribosomal display. Among these, the antibody phage display 
has developed into the most robust, versatile and widely used selection method during the past 
decade (Hust and Dübel 2004). It has proven its capability to supply human antibody fragments, 
binders to toxic or non-immunogenic substances and even fragile conformational variants. This 
technology is continuing to be optimized and improved (Kirsch, Zaman et al. 2005). Antibody 
display leads to the isolation of Ab fragments, which can be produced in E.coli. If entire antibodies 
like IgG are desired, the antibody variable (V) genes have to be transformed into related 
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eukaryotic expression systems containing the constant region of the antibody gene.  
 
Figure 2 Schematic drawings of IgG, Fab and scFv antibodies. (The drawing was derived 
from http://rzv054.rz.tu-bs.de/Biotech/SD/IgG_Fv.gif) 
2.3 IgG expression in mammalian cells  
During the production of IgG in mammalian cells, the antibodies have to travel along the cellular 
secretory pathway to reach the final destination outside of the host cells. The H and L chains first 
enter the endoplasmic reticulum as unfolded polypeptides, which are modified there to reach their 
final three-dimensional structure. Attributes such as conformation, structure of attached 
carbohydrates, and oligomeric state does not only control the functional properties but also are 
critical for intracellular transport. Newly synthesized polypeptides are retarded in exiting the ER 
before they acquire a so-called export-competent conformation (Hurtley, Bole et al. 1989; 
Hammond and Helenius 1995). Free H chains are not exported (Morrison and Scharff 1975), 
unless assembled with L chains into antibody molecules (Sonenshein, Siekevitz et al. 1978; 
Leitzgen, Knittler et al. 1997), while most L chains can be secreted as free molecules, such as 
monomer or dimer (Shapiro, Scharff et al. 1966; Skvortsov and Gurvich 1968; Hannam-Harris 
and Smith 1981; Hopper and Papagiannes 1986; Dul, Aviel et al. 1996). However, some Ig L 
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chains depend on Ig H chain association to be secreted (Oi, Morrison et al. 1983).  
The L chain plays an important role in IgG folding. L chains possess five cysteine residues, four 
of them are involved in two disulfide bonds that stabilize the variable (V) and constant (C) 
domains respectively, and a carboxyl terminal cysteine that is responsible for the intermolecular 
disulfide bond to the Ig H chain. The thiol group of the carboxyl-terminal cysteine of unassembled 
L chains causes a delay in secretion and the secreted L chains usually no longer possess 
unpaired cysteines, which is either covalently linked to a second L chain (or to H chain) or paired 
with a free cysteine (Knittler, Dirks et al. 1995; Reddy, Sparvoli et al. 1996). The removal of 
unpaired cysteines can result in a significant increase in antigen-binding activity and increased 
product yields (Schmiedl, Breitling et al. 2000). Export-incompetent Ig L chains may covalently 
interact with ER matrix proteins or noncovalently bind to BiP, an ER-resident molecular 
chaperone (Knittler and Haas 1992). In some cases, a single amino acid substitution in the light 
chain resulted in a loss of secretion competence (Wu, Hozumi et al. 1983, Dul and Argon 1990)). 
In the two classes of L chain, the assembling of λ light chain with IgG1, IgG2, and IgG4 H chain 
are more slowly than their κ counterparts (Montano and Morrison 2002).  
For the H chain, the correct assembly of H and L chains require the interaction of BiP with 
incompletely folded CH1 domains (Kaloff and Haas 1995). In the kinetic model for the folding of a 
Fab fragment, Pro159 within the Fd region is involved in the rate-limiting folding reaction (Lilie, 
Rudolph et al. 1995). Somatic mutations in CDR2 of the H chain can influence the intracellular 
half-lives of H and L chains (Martin, Wiens et al. 1998). In addition, the H chain is synthesized 
slower than L chain (Bergman, Harris et al. 1981; Schlatter, Stansfield et al. 2005).  
These molecular characteristics of IgG make it difficult to set a general profiling for all 
recombinant antibody mammalian production. 
2.4 Eukaryotic gene expression 
In eukaryotes, each cell packages its genome into a unique pattern of heterochromatin and 
euchromatin and this pattern is maintained after cell division. The chromatin structure plays a 
pivotal role in regulating gene transcription by marshalling access of the transcriptional apparatus 
to genes (Narlikar, Fan et al. 2002). The pattern of packaging into different chromatin states 
determines which genes will be active in a newly divided cell (Orphanides and Reinberg 2002). It 
is also referred to “position effect” for recombinant protein expression in stably transfected 
mammalian cells, where the genomic integration site has a dominant impact on the expression 
levels. Therefore, to achieve recombinant protein high-level expression mammalian cell lines, 
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high numbers of clones have to be screened to find a highly active position. This is a low 
efficiency and time consuming process. With the improvement of gene transfer methods and 
site-specific integration procedures, the expenditure clone screening may be reduced. Gene 
expression, from the activation of transcriptional regulators to the synthesis of a functional protein, 
is a multi-step process, starting in the cell nucleus with the synthesis of the primary transcripts 
that undergo several modifications including capping, splicing and polyadenylation, leading to the 
export of the mature mRNAs into the cytoplasm for translation into proteins. The multi-step gene 
expression is a continuous process, with each phase physically and functionally connected to the 
following one (Figure 3) (Orphanides and Reinberg 2002). The transcriptional apparatus plays an 
active role in recruiting the machinery that caps and processes the nascent RNA transcript 
(Proudfoot, Furger et al. 2002), the pre-mRNA splicing promotes transcription elongation in 
reverse (Fong and Zhou 2001). The mRNA exportation into the cytoplasm occurs even as the 
transcription is ongoing and is enhanced by the splicing (Reed and Hurt 2002).  
 
Figure 3 A Contemporary View of Gene Expression. Reproduced from literature (Orphanides and 
Reinberg 2002). 
Gene expression is regulated at multiple levels in a coordinated fashion. The promoter identity 
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not only regulates transcription, but also can impact pre-mRNA processing (Auboeuf, Dowhan et 
al. 2005). Transcription factors play an important role on the regulation of the gene expression by 
binding to DNA regulatory sequences. The activities of these factors are controlled by a diverse 
array of regulatory pathways. Regulating a rate-limiting step is an efficient way to control the 
overall rate of a multi-step process. However, there is a limit to the level of regulation that was 
achieved by controlling a single step if another soon becomes rate limiting. Different DNA 
sequences present in promoter regions, including untranslated and translated sequences, affect 
the rate of transcription, pre-mRNA processing, mRNA exportation and protein synthesis. There 
are additional sequences that govern the localization and stability of mRNAs and proteins 
(Orphanides and Reinberg 2002). The identification of these DNA sequence elements will 
enhance the understanding of the mechanism of gene expression and the possibility to regulate 
gene expression.   
2.5 Protein translation in eukaryotic cells 
Translation of mRNA in the eukaryotic cell is an extremely competitive process, the recruitment of 
the 40S ribosomal subunit onto the mRNA is believed to be the rate-limiting step of mRNA 
translation (Mathews, Sonenberg et al. 2000.). The translation initiation of eukaryotic mRNAs was 
supposed to use a scanning mode (Kozak 1980), which suggests that the 40S ribosomal subunit 
first recognizes the 5' terminus of the mRNA, in a process which is strongly stimulated by the 
presence of a cap structure, then migrates and stops at the first AUG codon in a favorable 
context for initiating translation. Recognition of the initiator AUG is followed by 60S ribosomal 
subunit joining to produce the translation-competent ribosome. The first-AUG rule is not absolute, 
subsequent revisions to the scanning model included the reinitiation and context-dependent 
leaky scanning mechanisms (Kozak 1989; Kozak 2002). They were used to explain the 
bypassing of upstream AUG codons for initiation because of unfavourable local sequences, or 
the affection of RNA secondary structure upstream or downstream of the initiation codon. By 
using point mutation analysis of the base around the AUG initiation codon, the optimal sequence 
for translation initiation by eukaryotic ribosomes was identified to be (GCC)GCCRCCaugG (R = 
purine) (Kozak 1986; Kozak 1987). Mutations within that sequence affected the yield over a 
20-fold range and it was showed that A or G in position -3 (3 nt upstream from the AUG codon, 
which is numbered +1 to +3) and G in position +4 make the strongest contributions (Kozak 1997). 
In the absence of -3R and +4G, mutations in positions -1 and -2 score strongly (Kozak and 
Neufeld 2003). Recognition of an AUG initiator codon in a suboptimal context was improved 
when a modest amount of secondary structure is introduced near the beginning of the 
protein-coding sequence (Kozak 1990). The 3’ UTR and poly(A) also exert an important role on 
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many mRNAs translation (Gray and Wickens 1998).  
2.6 Internal ribosomal entry site (IRES) mediated cap-independent translation 
The IRES-driven translation initiation was first demonstrated for picornavirus (Jang, Krausslich et 
al. 1988), which can recruit ribosomes directly to initiate translation using a 5’-end independent 
method, without a previous scanning of untranslated region of mRNA. IRESs are commonly used 
to direct the expression of the downstream cistrons of bicistronic or oligocistronic mRNAs. The 
translation initiation directed by an IRES requires IRES-specific trans-acting factors as well as the 
same set of initiation proteins necessary for cap–dependent mRNA translation initiation. The 
main difference compared to cap-dependent translation initiation was believed to be eIF4G. The 
C-terminal part of eIF4G contains binding sites for eIF3 and eIF4A, stimulates IRES-mediated 
translation (Ohlmann, Rau et al. 1995). The 40S ribosomal subunit is recruited to the IRES 
through interaction with eIF3 bound to the C-terminal domain of eIF4G. Binding of eIF4G to the 
mRNA does not occur through eIF4E because the mRNAs are not capped. eIF4G may bind to 
the IRES either directly or through a “linker” protein (Fig 4). Several cellular proteins have been 
shown to participate in IRES directed translation. Human La autoantigen, which is involved in 
regulating the initiation and termination of transcription by RNA polymerase III, stimulates 
IRES-dependent translation of PV mRNA (Meerovitch, Svitkin et al. 1993; Craig, Svitkin et al. 
1997; Izumi, Das et al. 2004). Polypyrimidine tract binding protein (PTB), a cellular RNA-binding 
protein (57 kDa) that binds to the 5' region of EMCV IRES, is required for the polio virus (PV) and 
EMCV IRES elements mediated translation (Hellen, Pestova et al. 1994; Kaminski, Hunt et al. 
1995; Kolupaeva, Hellen et al. 1996; Kaminski and Jackson 1998; Hunt and Jackson 1999; 
Gosert, Chang et al. 2000; Back, Kim et al. 2002). Poly(rC)-binding protein 2 (PCBP-2) and a 
heterogeneous nuclear ribonucleoprotein E2 (hnRNP E2) bind at multiple sites within the 
poliovirus IRES and abolish binding of poly r(C)–binding proteins causing a decreased translation 
in vitro (Blyn, Swiderek et al. 1996). And some other RNA-binding proteins, such as those 
upstream of N-ras (unr), heterogeneous nuclear ribonucleoprotein C (hnRNP C) and 
heterogeneous nuclear ribonucleoprotein L (hnRNP L) also modulate IRES-dependent 
translation (Hahm, Kim et al. 1998; Hunt, Hsuan et al. 1999; Boussadia, Niepmann et al. 2003; 
Kim, Paek et al. 2003). However, there was no single protein been identified that is essential for 
the function of every IRES. It was supposed that certain types of IRES have different 
requirements for cellular proteins. 
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Figure 4 Models for protein translation initiation complex formation. In 5´ cap–dependent 
initiation, the 40S subunit is recruited to the mRNA through its interaction with eIF3, 
which binds eIF4G. The latter initiation factor is part of eIF4F, which also contains eIF4A 
and eIF4E. Binding of eIF4E to the cap thus positions eIF4E at the 5´-end and positions 
the 40S subunit on the mRNA. In IRES-dependent translation, a 5´-end is not required. 
The eIF3–40S complex is believed to be recruited to the RNA by the interaction of eIF4G 
with cellular IRES-binding proteins, marked by “?” Reproduced from literature 
(Racaniello 2001). 
2.7 EMCV IRES 
Encephalomyocarditis virus (EMCV) is a member of the cardiovirus genus of the positive-sense 
picornaviruses. The picornavirus genomes RNA contain a highly structured IRES element in 5’ 
the untranslated region (5’ UTR) (Fig. 5). Picornaviral IRES elements have been classified into 
three groups by sequence and structural similarities. Type I IRES elements include those of 
enteroviruses and rhinoviruses, such as poliovirus (PV) and human rhinovirus (HRV). Type II 
IRES elements include IRES elements from cardioviruses and aphthoviruses, such as 
encephalomyocarditis virus (EMCV) and foot-and-mouth disease virus (FMDV).  The Hepatitis A 
virus (HAV) IRES element belongs to type III IRES.  
The EMCV IRES element is least affected by the flanked coding sequence, and the mediated 
translation is accurate and the most efficient in reticulocyte lysate translation extracts and culture 
cells among picornavirus IRES elements, which makes it attractive for driving heterologous gene 
expression (Borman, Deliat et al. 1994; Borman, Bailly et al. 1995; Borman, Le Mercier et al. 
1997; Hennecke, Kwissa et al. 2001). In the first description of EMCV IRES, the sequence 
between nucleotides 260 and 484 in the 5’UTR of encephalomyocarditis RNA was found to play a 
critical role in the efficient translation in both mono- and dicistronic mRNAs (Jang, et al. 1988). 
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Regions and particularly loops playing an essential role in EMCV IRES function have been 
identified subsequently. The 5´ border of the EMCV IRES has been mapped by deletion analysis 
to base 387 of the genome, a region near stem-loop G. The H segment facilitates translation 
initiation by stabilizing the IRES overall structure and aiding general protein binding (Hoffman and 
Palmenberg 1995). Stems J and K are important for IRES function, some of the single point 
mutants are highly defective, which is believed to be associated with the binding of translation 
factors (Duke, Hoffman et al. 1992; Hoffman and Palmenberg 1995; Houdebine and Attal 1999; 
Witwer, Rauscher et al. 2001; Clark, Robertson et al. 2003). So far, two conserved structure were 
identified to be essential for IRES function, include a conserved GNRA sequence (N, any 
nucleotide; R, purine) in stem-loop I of the EMCV IRES and a conserved Yn-Xm-AUG motif, in 
which Yn is a pyrimidine-rich region and Xm is a 15- to 25-nucleotide spacer followed by the 
initiator AUG codon. It was also reported that some point mutations could enhance IRES 
mediated translation initiation 1,5-5-fold time more active (Martinez-Salas, Saiz et al. 1993). 
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Figure 5 Consensus secondary structure of 5' UTRs of four related cardioviruses. The 
sequence shown is for EMCV-R. Changes in mengovirus and other EMCV strains 
(EMCV-B and EMCV-D) are given parenthetically as capital and lowercase letters, 
respectively. Stem-loop features are lettered consecutively, and AUG sequences 
(EMCV-R) are boxed. Reproduced from literature (Duke, Hoffman et al. 1992). 
2.8 Scaffolds/matrix attached region (S/MAR) 
The architecture of the nucleus includes chromatin and a nuclear matrix. Periodic and specific 
attachments of chromatin fibers to the nuclear matrix create the chromatin loop domains 
(Nickerson 2001), through which the eukaryotic genomes are organized into domains containing 
individual genes and gene clusters that have distinct patterns of expression during development 
(West, Gaszner et al. 2002). The loops are essential for DNA replication, transcription and 
chromosomal packaging (Jackson 1997). The formation of each loop is dependent on specific 
chromatin segments that function as an anchor to the nuclear matrix, which have been termed 
either `SARs' or `MARs' (collectively termed S/MARs) (Hart and Laemmli 1998). S/MAR anchors 
are necessary but not sufficient for chromatin loops to form, they work in a selective and dynamic 
fashion (Fig. 6) (Heng, Goetze et al. 2004). It was supposed that there are two types of S/MARs. 
Functional S/MARs serve as mediators to bring genes onto the nuclear matrix. Structural 
S/MARs serve as anchors, which are less dynamic compared with functional S/MARs. There is 
increasing evidence that S/MARs have both boundary and transcription regulation functions, 
which can dampen positional effects in eukaryotic cells as the insulating boundary elements and 
augment transcriptional levels by a enhancer-independent mechanism, and in some systems 
enhancers are fully active only when associated with S/MAR elements (Bode, Schlake et al. 1995; 
Bode, Stengert-Iber et al. 1996; Bode, Benham et al. 2000). "Insulators" regulate gene 
expression through establishing and maintaining the organization of the chromatin fiber within the 
nucleus by tethering the DNA to the nuclear matrix and creating chromatin loops (Byrd and 
Corces 2003). However, S/MAR sequences were required for the establishment but not for the 
maintenance of chromosomal insulation (Namciu and Fournier 2004).  
It was hypothesized that S/MARs reversibly associate with protein factors through a mechanism 
called ''mass binding phenomenon'' (according to which, low-affinity binding of many individual 
protein molecules to S/MAR results in strong and specific interactions and that can serve specific 
regulatory roles) to functionally compartmentalize eukaryotic genomes into chromatin domains 
(Bode, Goetze et al. 2003). Many protein factors were identified that interact with S/MARs. The 
nuclear lamina, scaffold-attachment factor A (SAF-A), scaffold attachment factor B1 (SAFB1) and 
SATB2 were relatively well studied. They are involved in chromatin remodeling and numerous 
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genes regulation.  
The 2.2 kb S/MAR element used in this study was the fragment released via EcoRI from the 14 
kb domain of the human interferon gene, which locates at upstream of well-characterized 
beta-interferon gene (Mielke, Kohwi et al. 1990).  
 
Figure 6 A proposed model for the S/MAR function in transcription/replication regulation.  
The left panel shows a gene located on the loop with a S/MAR in close proximity. When 
functional demands require the specific association of this gene with the transcriptional 
machinery located on the nuclear matrix, the S/MAR moves the gene to the nuclear 
matrix, thereby initiating gene expression (center). Following initiation, the gene is pulled 
in through the transcriptional machinery, thus completing the process (right). 
(Reproduced from Heng, et al. 2004). 
2.9 Recombinase mediated cassette exchange (RMCE) 
The first described site-specific recombinases, Cre from P1 phage and Flp from yeast, catalyze 
recombination between two 34-base pair recognition sites, lox and FRT, respectively, resulting in 
excision, inversion, or translocation of DNA sequences depending upon the location and the 
orientation of the recognition sites (O´Gorman, Fox et al. 1991; Fukushige and Sauer 1992). The 
integration reaction is often limited with wild-type recombinase recognition sites due to the 
re-excision of the recombined product. Therefore mutant target sites were developed to increase 
the efficiency of Cre/Flp-mediated insertion or replacement reactions. The recombinase mediated 
cassette exchange (RMCE) strategy was developed using heterospecific sites, such as 
combination of the LE/RE mutant and lox2272 for Cre (Araki, Araki et al. 2002) or F and F3 for 
Flp (Seibler, Schubeler et al. 1998). RMCE has been successfully used to achieve predictable 
gene expression in cell culture and for the systematic creation of transgenic animals (Baer and 
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Bode 2001). The improved RMCE methods permit expression in the absence of any 
co-expressed selection marker gene in ES cells (Seibler, Schubeler et al. 1998; Feng, Seibler et 
al. 1999).  
The Flip mediated RMCE method tested in this work was developed by Seibler et al. (Seibler, 
Schubeler et al. 1998). Flp-RMCE utilizes a set of two 48 bp Flp target sites, wild-type F and 
mutant F3, which was mutated in the 8 bp spacer localized between the Flp binding elements 
(Schlake and Bode 1994). Flp can mediate recombination between the F3/F3 with the same 
efficiency as between the wild-type sites (F/F), but it does not catalyze recombination between 
the F/F3 sites (Seibler and Bode 1997). For enhancing the system, a hygromycin 
phosphotransferrase and thymidine kinase (hygtk) positive/negative fusion selection marker was 
inserted between the heterospecific tags, and the construct was integrated into the genome of 
embryonic stem (ES) cells. The successful Flp-mediated replacement of the hygtk cassette is 
enriched by ganciclovir (GANC) selection for cells that lack the encoded fusion protein (Fig. 7). 
Using this method, after positive plus negative double selection, the targeting efficiency was 
about 54% to 100% at different gene loci in murine ES cells. The stably transfected CHO-K1 cell 
line used in this study was with a single copy integration tag cassette, which was established by 
Dr. Alexandra Baer (in her Ph.D. work at GBF). Here the insertion “hygtk” fusion selection marker 
between F/F3 tags was further modified to hygromycin-thymidine kinase-enhanced green 
fluorescence protein (hygtkgfp) and was flanked by two S/MAR elements.  
 
Figure 7 Schematic representation of recombinase mediated cassatte exchange (RMCE). 
(A) Outline of a tag-and exchange experiment. (B) Use of the Flp-RMCE to exchange a 
genomically anchored plus/minus selection marker (hygtk) for an expression cassette. 
Half arrows mark the positions of heterospecific FRT-sites (solid, wild type; light, mutant 
F3). Reproduced from literature (Seibler, Schubeler et al. 1998). 
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2.10 Breast Cancer 
Not like other disease, the incidence of breast cancer is increasing (Harris, Lippman et al. 1992; 
Clarke, Glaser et al. 2002). By far, it is the most frequent cancer of women (23% of all cancers), 
with an estimated 1.15 million new cases in 2002 worldwide, ranking second overall when both 
sexes are considered together. More than half of the cases are in industrialized countries—about 
361,000 in Europe (27.3% of cancers in women) and 230,000 in North America (31.3%) (Parkin, 
Bray et al. 2005). In part, the high incidence in the more affluent world areas is likely because of 
the presence of screening programs that detect early invasive cancers, some of which in 
developing areas would otherwise have been diagnosed later or not at all (Parkin, Bray et al. 
2005). About 5% of breast cancer is attributable to rare high-penetrance mutations in a small 
number of specific genes (eg, BRCA1, BRCA2, ATM, PTEN, and TP53); mutations in BRCA1 
and BRCA2 account for up to 50% of hereditary and familial breast cancer. Each gene shows 
some differences in the familial pattern of cancer: BRCA1 is more strongly associated with 
ovarian cancer, BRCA2 with male breast cancer, ATM with radiosensitivity, PTEN with Cowden’s 
syndrome (including hamartomas of the skin and other organs), and p53 with Li-Fraumeni 
syndrome (including sarcomas and a variety of other tumors) (Rahman and Stratton 1998; Chen 
and Hunter 2005). However, etiological factors of most breast cancer cases remain unclear. It 
was estimated after epidemiological survey of population-attributable risks that at least 45% to 
55% of breast cancer cases in the United States might be explained by later age at first birth, 
nulliparity, family history of breast cancer, higher socioeconomic status, earlier age at menarche, 
and prior benign breast disease (Madigan, Ziegler et al. 1995). But it is difficult to find substantial 
evidence to support a major role of environmental risk factors in the etiology of breast cancer 
(Laden and Hunter 1998). Early detection and early treatment of breast cancer at a stage when it 
is potentially curable have reduced the mortality of breast cancer during the past decade (Peto, 
Boreham et al. 2000). Now, recombinant IgG has been used as an adjuvant therapy to standard 
treatments of breast cancer. It has shown significant efficacy in the treatment (Mehren, Adams et 
al. 2003). 
2.11 Mucin 1 (MUC1) 
2.11.1 Molecular character 
MUC1 is a member of the mucins family, which was the first defined tumor associate antigen in 
1980s. It is a type I transmembrane molecule, which consists of a small transmembrane and 
intracellular tail and an extracellular domain consisting of a variable number (30–100) of tandem 
repeats (VNTR) segments of 20 amino acids (Fig. 8). Mucins are large glycoproteins that are 
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heterogeneously expressed by a wide variety of epithelial cells. Mucin proteins are characterized 
by the presence of VNTR amino acid sequences (depending on mucin type and also subject to 
allelic polymorphism between individuals). Serine and threonine residues constitute a large 
proportion of mucin VNTR sequences, giving rise to numerous potential O-glycosylation sites. 
Carbohydrate constitutes the major portion of the mature mucin molecule (Gendler and Spicer 
1995).  
The peptide core is densely coated with oligosaccharides, conferring a rigid rod-like structure, 
which can extend several hundred nanometers from the apical cell surface into the lumen of 
ducts and glands (Gendler and Spicer 1995; Brayman, Thathiah et al. 2004). Cancer-associated 
MUC1 is aberrantly overexpressed (10–40 fold) in a variety of cancers and incompletely 
glycosylated. As a result internal sugar units and naked peptide sequences are exposed, which 
are cryptic in the normal mucin molecule. It makes them useful targets for antibodies and cellular 
immunity. MUC1 glycoprotein is often found in circulation in late-stage breast and lung cancer. It 
has been used as a tumour marker (CA15.3) in the follow-up of breast cancer patients (Berruti, 
Tampellini et al. 1994). 
 
Figure 8 Schematic diagram of the size and structure of the full length MUC1 protein relative 
to the plasma membrane. The horizontal bar indicates the distance that most cell 
surface proteins extend into the pericellular space. The three major domains of MUC1 
are indicated to the left:  an N-terminal, extracellular domain (ECTO); a single, 
membrane spanning domain (TM) and a C-terminal cytoplasmic domain (CT). 
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Reproduced from literature (Brayman, Thathiah et al. 2004). 
2.11.2 Physiological function of MUC1 
The high degree of glycosylation is believed to provide lubrication, prevent dehydration, and offer 
protection from proteolysis, but the knockout mice, lacking MUC1, had no alteration in their 
development and in their glandular morphology (Spicer, Rowse et al. 1995). The huge 
extracellular domain protects against attack by sterically inhibiting microbial access to the cell 
surface (Vimal, Khullar et al. 2000; Lillehoj, Kim et al. 2002), which is a process that normally 
protects against infection. In addition, MUC1 modulates cell-cell and cell-extracellular matrix 
(ECM) interactions by steric hindrance of the extracellular domain (Wesseling, van der Valk et al. 
1996; Komatsu, Carraway et al. 1997).  
MUC1 seems to be involved in signal transduction through its cytoplasmic tail, which was shown 
to be associated with β-catenin (Yamamoto, Bharti et al. 1997), as well as Grb2/Sos (Pandey, 
Kharbanda et al. 1995). MUC1 could down-regulate the activities of other molecules such as 
catenins, cadherins or integrins via signal transduction events (Agrawal and Longenecker 2005). 
Activation of erbB1 with EGF induces tyrosine phosphorylation of the MUC1 cytoplasmic tail (Li, 
Kuwahara et al. 2001) and activation of ERK 1/2 (Schroeder, Thompson et al. 2001). Moreover, 
EGF mediated activation of ERK 1/2 was drastically enhanced in the presence of high levels of 
MUC1 in the mouse mammary gland (Schroeder, Thompson et al. 2001). The MUC1-induced 
signal transduction could also be involved in a Src family kinase, phosphoinositol 3-kinase, 
phospholipase C and lipid rafts. The tumor cells metastasis may be related to the functions of 
MUC1 involved a calcium-based pro-migratory signal transduction (Rahn, Shen et al. 2004). The 
MUC1 VNTRs are necessary for an ordered tertiary structure and also important for intercellular 
adhesion molecule-1 (ICAM-1) recognition, which are involved in the regulation of T cell 
responses (Agrawal, Krantz et al. 1998; Kam, Regimbald et al. 1998; Agrawal and Longenecker 
2005). 
2.11.3 MUC1 induced immune response 
It was confirmed that immunisation with MUC1 antigenic epitopes can induce T-cell proliferative 
responses as well as MHC-restricted cytotoxic T-cells. A specific T proliferative response directed 
against an epitope of the human MUC1 tandem repeat domain was found in 1990’s (Spicer, 
Rowse et al. 1995), however the MUC-1-directed immune response is not limited to the 
extracellular tandem repeat domain (Brossart, Heinrich et al. 1999). Murine experiments have 
shown that immunization with MUC1 polypeptides without tandem repeats is effective in inducing 
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a tumor rejecting anti-MUC1 immune response (Taylor-Papadimitriou, Burchell et al. 2002). In 
addition to the T-cell response, a predominant antibody response was documented following 
serial vaccinations with a peptide-mannan fusion protein (Apostolopoulos, Osinski et al. 1998). In 
some studies, only antibody but not T-cell responses to MUC1 was observed in MUC1 transgenic 
mice immunized with vaccinia-MUC1-IL-2 (Acres, Apostolopoulos et al. 1999). It was found in 
clinical epidemiological follow-up studies that elevated natural antibodies to MUC1 in early-stage 
breast cancer patients could benefit long term survival, which was attributed to the controlling of 
tumor cells dissemination and outgrowth by aiding the destruction of circulating or seeded 
MUC1-expressing tumor cells (von Mensdorff-Pouilly, Verstraeten et al. 2000).  
2.11.4 The human anti-MUC1 antibody IIB6 
Monoclonal antibody therapy has emerged as an important therapeutic modality for cancer. Most 
of the MAb employed in early clinical trials were derived from mice. Patients exposed to them 
developed human anti-mouse antibody (HAMA) responses, which limited the number of 
treatments patients could safely receive. The possibility to create fully human immunoglobulins 
limited the capacity to induce HAMA. Recently, a human anti-breast cancer MUC1 antibody scFv 
fragment was developed using phage display technology (by Dr. Lars Toleiks, a former Ph.D 
student of Professor Dr. Stefan Dübel). A patient suffering from breast cancer was immunized 
with synthesized glycopeptide of the tumor associated MUC1 VNTR region. Then a human 
recombinant antibody phagemid library was established based on the peripheral lymphocytes 
donated by the immunized patient. Panning was performed on tumor associated MUC1 peptide 
and one specific antibody was isolated. The VH gene belongs to the VH1 subfamily and the VL 
gene belongs to the Vλ3 subfamily. The binding epitope is “XRPAP”, a linear epitope in the 
MUC1 VNTR region. The isolated human anti-MUC1 scFv antibody was expressed in E.coli and 
characterized using FACS on different breast cancer cell lines. Further, the binding kinetics 
parameter was measured using the surface plasmon resonance (SPR) technology. It was 
confirmed that the IIB6 scFv could specifically bind on tumor associated MUC1 antigen and 
breast cancer derived cell lines. The binding affinity on the synthesized MUC1 16-mer biotin 
conjugated glycopeptide is KD (M) 2,28x10e-7. 
2.12 Purpose of this study 
Cultivated mammalian cells are the dominant system for the production of recombinant proteins 
for clinical applications because of their capacity for proper protein folding, assembly and 
post-translational modification (Wurm 2004). The productivity of mammalian cells cultivated in 
bioreactors has increased remarkably over the last two decades, the increasing in volumetric 
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productivity resulted mainly from improvements in media composition and process control (Wurm 
2004). Current strategies to improve expression systems comprise: enhancement of gene 
expression rates, enhancement of secretion, enhancement of polypeptide folding and assembly, 
prevention of premature product degradation, simplification of the procedure of high producer 
screening, host cells modification and optimization of subsequent feeding.  
In this study, a comparative analysis of different vector designs of monocistronic and bicistronic 
constructs with different promoter and cistron arrangement should be made in transiently 
transfected HEK 293T and CHO-K1 cells. Stable transfected CHO cell lines should be 
established to compare the affection of different version of vectors on stable mammalian IgG 
expression. The affection of cistron arrangement and the impact of H and L chain on bicistronic 
IgG expression should be analyzed. Methods should be explored to investigate the optimal ratio 
of HC:LC intracellular expression levels for efficient IgG folding and assembly. 
Skeleton or matrix attached regions (S/MAR) are genomic elements that were found to be able to 
augment gene expression and orchestrate the local chromosome structure (Agarwal, Austin et al. 
1998; Bode, Benham et al. 2000; Kurre, Morris et al. 2003). In this study, the impact of S/MAR 
element on recombinant mammalian IgG expression, including the stability and expression levels 
should be investigated and the possibility of developing an alternative strategy using nonviral 
episomes for recombinant IgG production should be explored.  
Finally, a human anti-MUC1 antibody should be transformed from the scFv to the IgG format and 
produced in mammalian cells for characterazation. The character of the mammalian produced 
IgG from different cell lines would be evaluated. 
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3.1 Vector construction and elements 
In eukaryotic cells, gene expression is a multi-step interconnected process. To develop vectors 
for IgG expression in mammalian cells, the elements involved in gene expression were chosen as 
candidates for vector variation and a comparative analysis. The cytomegalovirus immediately 
early promoter and the cellular EF1-α promoter were used to drive the transcription of the gene of 
interest. The optimal Kozak sequence 5’-GCCACCATGG-3‘ was arranged as the cap-dependent 
translation initiation, in the polycistronic vectors the EMCV IRES was used to mediate internal 
protein translation initiation. The human antibody Vκ3 (hVκ3S) subfamily signal sequence and 
the mouse antibody heavy chain VH3 (mVH3S) subfamily signal sequence containing a synthetic 
intron were used for secretory IgG expression. The BGH polyadenylation sequence was used to 
mediate transcription termination and polyadenylation. A series of monocistronic and bicistronic 
vectors were constructed. The pre-mRNA transcript from a monocistronic and a bicistronic 
construct is depicted in figure 9. To speed up the analysis, a variant of the yellow fluorescence 
protein (YFP) gene, Venus (Nagai, Ibata et al. 2002), was used as a reporter in the bicistronic 
constructs to determine translation efficiencies. The construction of plasmids are depicted in 
figure 10 A and B  
 
 
 
Figure 9 Schematic representation of a monocistronic and a biscistronic transcript. Insertion 
elements are not drawn to scale. 
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B 
Figure 10 Flow chart of the construction of IgG expression plasmids (A) and polycistronic 
plasmids with YFP gene as reporter (B). The elements are not drawn to scale. Detail 
descriptions of indicated cloning steps refer to chapter 5.2.4. 
 
 22
3 Results 
3.2 The impact of cistron arrangement on IRES mediated bicistronic gene expression  
To analyze of the impact of cistron arrangement and the affection of H and L chain on IgG 
expression, a series of bicistronic and tricistronic plasmids using an YFP variant (Venus) as 
reporter gene were constructed (Fig. 11). A comparative analysis of the cap-dependent and the 
IRES-mediated cap-independent translation efficiency was performed in 293T and CHO-K1 cells. 
In all the constructs, the IRES element used was an EMCV IRES variant with one C deletion 
between base 270 and 280, and an A345G mutation. Transiently transfected cells samples were 
harvested and analyzed by flow cytometry (FACSCalibur with CellQuest software).  
 
Figure 11 Schematic representations of the vectors for the expression of the mouse/human 
chimeric IgG and yellow fluorescence protein genes. CMV: CMV immediately early promoter, 
YFP: a variant of yellow fluorescence protein gene (Venus), IRES: internal ribosome entry 
site fragment (a variant of EMCV 5’ UTR nt260 to 848), Vκ3S: human antibody Vκ3 subfamily 
signal sequence, LC: IgG light chain gene, PA: BGH polyadenylation sequence, VH3S: 
Mouse antibody heavy chain VH3 subfamily signal sequence, HC: IgG1 heavy chain gene. 
The elements are not drawn to scale. 
 
After collecting 10000 to 50000 events, living cell subsets were gated within the total forward-side 
scatter dot plots based on mock-transfected control cells. The quadrant was set to define the 
positive cells as those falling in the upper-left. The mean fluorescence intensity (MFI) for the YFP 
(FL1) was determined on the events falling within the upper-left of the quadrant (Fig. 12A). Three 
independent transfection experiments were performed using the five different constructs in 
transiently transfected 293T cells (Fig. 12B). When YFP was positioned as the first cistron 
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expressed by cap-dependent translation initiation, pDYIH and pDYIL gave nearly equal 
fluorescence signals; when YFP was positioned as the second cistron at downstream of IRES 
element, the pDHIY and pDLIY expressed the YFP gene almost equal to each other, but 2-4 fold 
lower than from 5’ cap-dependent translation (pDYIH and pDYIL). The reporter gene transient 
expression levels were not significantly affected by the other cistron being L or H chain.  
 
A 
 
B 
Figure 12 Comparison of cap-dependent and IRES mediated cap-independent YFP 
expression in transiently transfected 293T cells. (A) Fluorescence distribution after flow 
cytometry of transiently transfected 293T cells. 48 hours after transfection, cells were 
harvested and analyzed by flow cytometry. Fluorescence emission (FL1) was analyzed 
for yellow fluorescence. Forward and side scatter was used to establish a collection gate 
through which dead cells and debris were excluded. (B) Quantitation of YFP 
fluorescence intensity of transient transfected HEK 293T cells measured by flow 
cytometry 48 hours after transfection. Standard error variance were from three 
independent experiments 
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Interestingly, in pooled stably transfected CHO-K1 cell lines, pDYIL gave a 2-fold higher 
fluorescence signal compared to pDYIH (Fig.13A). The prevalence of the positive cells in pools of 
cells transfected with pDYIL transfected was also about 2-fold higher than cells transfected with 
pDYIH. 
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Figure 13 Comparison of reporter YFP gene expression by cap-dependent and IRES 
mediated cap-independent way in stably transfected CHO-K1 cells. (A) Fluorescence 
distribution of pooled stably transfected CHO-K1 clones measured by flow cytometry 
after two weeks selection with 500 µg/ml G418. (B) Quantitation of mean fluorescence 
intensities of pooled stably transfected CHO-K1 cells cultured for 3 days and 35 days in 
absence of selection pressure. 
 
Here, the IgG H or L chain positioned as the downstream cistron obviously affected on 
cap-dependent translation initiation of the upstream cistron (Fig. 13B). Repeated experiments 
showed the same result. For YFP being placed at second or third cistron, the IRES mediated YFP 
 25
3 Results 
expression 3 days after selection gave signals at the same level (Fig.13). 35 days after selection, 
reporter gene expression from the construct pDHIY is about 2-fold higher than pDLIY and in the 
same range of the expression levels from pDYIH. The prevalence of positive among the gated 
cells, pDHIY was about 8,88%, pDLIY was about 14,19%, pDYIH was about 6,86% and pDYIL 
was about 14,03% (data not shown in the figure). This indicates that constructs with the same 
elements have a similar prevalence of detectable YFP positive cells one month after selection. 
The bicistronic construct with H chain as first cistron seems to be beneficial for stable protein 
expression. IRES mediated YFP expression appeared to be about 3-5 folds lower than 
cap-dependent translation in CHO-K1 cells. In the tricistronic construct, where the YFP gene was 
positioned as the third cistron, the YFP expression was found to be not reduced compared to 
bicistronic constructs in both transiently transfected 293T and stably transfected CHO-K1 cells, 
which is consistent with a previous report (Zhu, Musco et al. 1999). These results indicted that the 
cistrons following IRES in combination with antibody genes in the context of our vectors are 
translated efficiently, however not as efficient as cap-dependent translation of the first cistron. 
3.3 Transient antibody expression in 293T and CHO-K1 cells 
 
Figure 14 Schematic representations of the vectors for the IgG expression in mammalian 
cells. For abbreviations see Figure 11. The elements are not drawn to scale. 
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To assess the antibody expression capabilities of the constructed vectors, we transfected HEK 
293T and CHO-K1 cells with monocistronic and bicistronic vectors with two different promoters 
and cistron arrangements (Fig. 14). 48 hours after transfection, the IgG expression levels in the 
supernatant were measured by sandwich ELISA. Since free IgG H chains are not secreted 
(Morrison and Scharff 1975), detection of the γ heavy chain in the supernatant should represent 
the expression levels of entire IgG molecules. Different combinations of monocistronic 
expression constructs gave different expression levels (Fig. 15). The combination of 
monocistronic L and H chain expression constructs driven by EF1-α promoter gave the highest 
yield. For bicistronic expression, the EF1-α promoter driven bicistronic expression construct with 
L-IRES-H arrangement in 293T cells gave an about 2-fold higher IgG expression than all other 
bicistronic expression constructs. The optimal EF1-α driven bicistronic expression construct and 
the cotransfected EF1-α promoter driven two monocistronic ones show a similar IgG expression 
levels (Fig. 15). 
 
Figure 15 Comparison of the mouse/human chimeric IgG1 transient expression levels from 
different constructs in 293T and CHO-K1 cells. 293T and CHO-K1 cells were seeded in 
24-well plate the day before transfection in 1mL appropriate medium and transfected 
with monocistronic and bicistronic plasmid, 48 hours after transfection, IgG 
concentration in the supernatant was determined by ELISA. Standard error variance was 
from three independent experiments. 
3.4 IgG1 expression in stably transfected CHO-K1 clones 
Based on the transient expression data, the bicistronic expression plasmids pDH1-215 and 
pDL1-215 and a combination of the two-monocistronic expression plasmids pSH2-215 and 
pSL2-215 were used to transfect into CHO-K1 cells to compare the expression levels of stable 
cell lines. After two weeks of selection with 500 µg/ml G418, 15 clones were randomly picked 
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from each transfection and the antibody expression levels were measured by ELISA. 6-8 clones 
per transfection expressed detectable levels of antibody. The 15 random clones from the 
cotransfection of two-monocistronic plasmids resulted in an expression patterns equal to the one 
from bicistronic expression constructs (Fig. 16). In transient expression, the combination of two 
EF1-α promoter driven monocistronic plasmids gave a higher yield than the combination of CMV 
promoter driven monocistronic plasmids and the bicistronic plasmids pDH1-215 and pDL1-215. 
This may suggest that for stable expression, the site of integration has a dominant impact. The 
bicistronic vectors allow stable expression with yield comparable to the monocistronic vectors.  
 
Figure 16 IgG expressions of randomly selected stable CHO-K1 clones. Human/mouse 
chimeric IgG 215 expression levels for clones obtained by either cotransfection with two 
monocistronic vectors pSH2-215 and pSL2-215, or a bicistronic vector pDH1-215, 
pDL1-215 respectively. The IgG concentration in the supernatant was determined by 
ELISA. It is shown of 15 clones ranked from lowest to highest expression levels. 
 
To evaluate the long-term stability of EMCV IRES mediated bicistronic antibody expression, 
CHO-K1 cells were transfected with the bicistronic human IgG1 expression plasmid pDH1-IIB6 
and selected with G418. Of 51 clones tested after selection, 23 clones, about 45% expressed 
detectable levels of antibody (Fig. 21A). The highest expressing clone (Lj98-1-13) was scaled up 
to 6-well plate, cultured with medium without selection pressure and evaluated for antibody 
expression for a period of 300 days (Fig. 17). After 100 days of culture in absence of G418 
selection, the expression level reduced to 50% relative to the start level. After 300 days, the 
tested clone still expressed detectable levels of antibody, about 10% relative to the start levels. 
The stability of this clone was at least equivalent to previously reported for the recombinant 
protein production in CHO cells (Barnes, Bentley et al. 2003). This indicates that EMCV IRES 
mediated bicistronic expression does not affect the stability of protein expression and can be 
used to generate highly expressing stable clones. 
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 Figure 17 Evaluation of the stability of IgG expressions using EMCV mediated bicistronic 
vector in CHO-K1 cells. A stable CHO-K1 clone expressing human IgG was isolated and 
kept culture over 300 days. Culture medium supernatant was harvested at different 
period of time, centrifuged at 12000rpm for 5min to get rid of cell debris, was quickly 
frozen the in liquid nitrogen and stored at –80°C. IgG concentration in the supernatant 
was determined by ELISA in one experiment. 
 
The causes of the loss of productivity in absence of G418 were studied by subcloning analysis of 
this clone over a period of 5, 35 and 300days respectively. Among the randomly picked clones, 
100% of the cells from cultured in absence of G418 selection over 5 and 35 days gave detectable 
IgG in the supernatant, the expression levels from different clone were nearly in the same level, 
which indicted the unity of the selected monoclonal cell lines. The IgG expression levels from the 
cells cultured over 35 days were slightly down regulated compared the cells cultured over a 
period of 5 days in absence of selection (Fig. 18A, B). The subcloning analysis of the cells 
cultured in absence of selection over a period of 300 days showed only about 10% of the picked 
200 clones expressed detectable IgG in the supernatant and the expression levels were also 
apparently down regulated (Fig. 18C). 24 clones were further selected from the subcloning of the 
cells cultured in absence of selection over a period of 300 days and cultured in 24-well plate, and 
reselect with G418 (500 µg/mL) for 2 weeks. All the cells kept living under selection pressure, the 
IgG expression levels in the supernatant were slightly increased compared to the expression 
levels before selection, but the down regulated cells did not recover to the original expression 
levels (Fig. 19). This might indicate that the loss of productivity was not likely due to the loss of 
the genes of interest.  
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Figure 18 Subcloning analysis of the human IgG expression in absence of G418 selection over a 
different period. Human IgG expression in the supernatant for subclones obtained from the 
stable clone cultured over a period of: (A) 5 days, (B) 35 days and (C) 300 days in absence of 
selection, here is shown randomly selected clones, ranked from highest to lowest expression 
level. Antibody concentration in the supernatant was determined by using ELISA. 
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Figure 19 IgG expression levels from subclones of the clone culture over a period of 300 days in 
absence of selection. 24 clones were randomly picked, culture in 24-well plate with 1 mL 
medium, the cells were selected under G418 (500 µg/mL) for 2 weeks. IgG expression levels 
in the supernatnant were determined by ELISA when the cells reach mono-layer confluent 
before and after selection. 
 
3.5 The impact of scaffold matrix attached region (S/MAR) elements on IgG expression 
S/MARs are DNA sequences that bind isolated nuclear scaffolds or nuclear matrices in vitro with 
high affinity (Hart and Laemmli 1998). The human interferon beta domain S/MAR element was 
shown to confer position-independent gene expression and augment gene transcription 
increasing the gene expression levels (Bode, Benham et al. 2000). To apply these findings in the 
IgG expression vectors, the 2,2kb S/MAR element from the human beta interferon gene was 
cloned into a bicistronic human anti-MUC1 IgG expression construct upstream or upstream and 
downstream of the expression cassette (Fig. 20). The impact on IgG expression levels was 
analyzed. 
 
pDH1 
pIDH1 
pI2DH1 
 
Figure 20 Schematic representation of the bicistronic vectors with or without S/MAR, pDH1 
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bearing no S/MAR element, pIDH1 bearing one S/MAR element at upstream of CMV 
promoter, pI2DH1 bearing two S/MAR element flanking the bicistronic expression 
cassette. Elements are not drawn to scale. 
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Figure 21 The impact of S/MAR on IgG1 expression in stable CHO-K1 clones. The antibody 
concentration in the supernatant is shown for randomly selected clones ranked from 
lowest to highest expression level. (A) Transfected with pDH1 bearing no S/MAR 
element; (B) transfected with pIDH1 bearing one S/MAR element at upstream of CMV 
promoter; (C) transfected with pI2DH1 bearing two S/MAR elements flanking the 
bicistronic expression cassette. 
 
In stably transfected CHO-K1 cells, the percentage of randomly selected stable CHO-K1 clones 
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expressing detectable IgG levels, for pDH1 without S/MAR was about 47% (24/51), for pIDH1 
with one S/MAR was 50% (22/44) and for pI2DH1 with two S/MAR was 75% (37/49) (Fig. 21 A, B, 
C). It seems that S/MAR elements could increase the prevalence of positive clones when two 
S/MAR elements are flanking the expression cassette. However, among the defined amount of 
screened clones, the highest producing clone was isolated from the vector without S/MAR 
element. To compare the antibody expression levels from single clones, the two highest 
expression clones were selected from each transfection and cultured in 6-well plates. Antibody 
yields in the supernatant was determined by ELISA. The highest expressing clone from pDH1, 
gave about 5-8 times higher IgG yields than the others (Fig. 22). That result is partially 
inconsistant with a previous report that a chicken lysozyme 5’ MAR element could significantly 
increase the prevalence of positive clones and the expression levels of single clones (Zahn-Zabal, 
Kobr et al. 2001).  
 
Figure 22 Anti-MUC1 IgG1 expression levels of stably transfected CHO-K1 clones from 
constructs with or without S/MAR elements. 3 days after selection, 106 cells were 
counted and culture in 3mL medium for 24 hours in triplicate, antibody concentration in 
the supernatant was determined by using IgG capture ELISA. 
 
It was shown that the S/MAR element when linked directly to an upstream transcription unit can 
mediate episomal replication of circular DNA and keep mitotic stability in mammalian cells in the 
absence of selection (Jenke, Stehle et al. 2004). From this, the idea of designing nonviral 
episomal vectors for IgG expression was accrued. To make a comparative analysis of the ability 
of the S/MAR element mediated episome on IgG expression, the 2,2kb human beta interferon 
gene S/MAR element was cloned into a tricistronic IgG expression vector pTLIY (Fig. 23).  
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Figure 23. Schematic representation of episomal vector pEPI-TLIY and reference vector 
pTLIY. The gene elements are not drawn to scale. 
 
The transient expression of the reporter gene YFP from the S/MAR containing vector pEPI-TLIY 
was found to be lower than from pTLIY in transiently transfected CHO-K1 cells (Fig 24). Pools of 
stably transfected CHO-K1 cells obtained by selection with G418 (500µg/mL for 2-3 weeks) were 
analyzed and sorted by FACS. And it was compared with cells obtained without selection from 
the same transfection (Tab. 2 and Fig. 23). 
 
Figure 24 Reporter gene YFP expression levels in transiently transfected CHO-K1 cells from 
tricistronic pTLIY and pEPI-TLIY. YFP fluorescence intensity was measured using a 
TECAN GENios, cells transfected with only transfection reagents was set as 
background control. 
 
Table 2 Flow cytometry analysis of pools of stably transfected CHO-K1 cell with or without 
selection  
 
The cells transfected with pEPI-TLIY expressed slightly lower levels of YFP than the control cells 
transfected with pTLIY (Table 2). In pools of transfected cells cultured for one month without any 
selection, YFP expression from pEPI-TLIY transfected cells was about 3-5 times less than from 
pTLIY transfected cells. This result showed that when a 2,2 kb S/MAR fragment was directly 
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placed at downstream of a polycistronic transcription unit and upstream of the polyA signal, the 
stability of the foreign gene expression was not increased but the expression levels of the 
reporter gene YFP were decreased. To test the expression levels from single clones, 20 clones 
expressing detectable levels of YFP were isolated by FACS sorting, cultured in 24-well tissue 
culture plates and IgG concentration in the supernatant was determined by ELISA (Fig. 25). The 
average expression levels from the selected pEPI-TLIY single clones were lower than from the 
reference clones (pTLIY). Therefore, it might be argued that the expression levels from 
pEPI-TLIY are generally lower than from pTLIY. 
 
Figure 25 Mouse/human IgG expression levels from randomly selected clones. Antibody 
concentration in the supernatant was determined by ELSIA, here is shown for the randomly 
selected clones ranked from highest to lowest expression level. 
 
To test if the plasmid DNA was integrated into genome of the host cells or replicated as an 
episome, six clones were randomly picked and cultured in 6-well tissue culture plates.  A 
plasmid rescue experiment was performed, but no relevant plasmid could be rescued from stable 
clones, in contrast, plasmids were successfully rescued from transiently transfected controls. 
PCR amplification of the IgG heavy chain constant region was performed to test for integration 
using genomic DNA as template. A band of about 1-kb was found from most of the clones (5/6) in 
the pEPI-TLIY transfected cells with or without selection (Fig. 26). This demonstrated that when 
the S/MAR element is directly linked to one polycistronic transcription unit, the plasmid rather 
integrates into chromosome than replicates as an episome, although, further evidence needs to 
be collected.  
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Figure 26 PCR amplification of IgG constant region using genomic DNA as template. 
GeneRuler 1kb DNA ladder was used as fragment sizes reference, the genomic DNA 
was isolated from 6 randomly selected clones in each experimental group and was 
identified by PCR amplification of the H chain constant region. The clones with positive 
integration should have a band around 1kb. 
3.6 The impact of the H chain to L chain ratio on IgG production  
It is a crucial step for IgG production in mammalian cells that the H chain and L chain 
polypeptides in the endoplasmic reticulum yields properly folded and assembled structures with 
full biological activity. When folding promotion is not sufficient, proteins are retained in the ER and 
eventually retranslocated to the cytosol for degradation by the ubiquity proteasome pathway. The 
folding and assembly of H chain and L chain relies on the chaperone system in the ER and the 
HC:LC ratio could influence assembly time (Gonzalez, Andrews et al. 2002). To investigate the 
optimal ratio of intracellular H chain and L chain expression levels for IgG production, a series of 
EMCV IRES variants with different translation efficiencies were used (Chongchong Zhang’s 
master thesis). The translation efficiency of the different IRES variants were compared to 
cap-dependent translation, by using bicistronic constructs with inverse cistron arrangement. The 
translation efficiency of the IRES variants ranged from 0,03 to 0,6 compared to cap-dependent 
translation. The L chain expression levels were set as constant obtained by positioning the L 
chain gene as the first cistron in a bicistronic construct. The H chain expression levels were set 
as variate obtained by using EMCV IRES variants with different translation efficiency. Thus, it 
was supposed that the IgG expression levels depend on the H chain expression levels, since the 
cap-independent translation efficiency is lower than cap-dependent translation efficiency. The L 
chain and H chain were translated from the same mRNA, the lgG expression levels may reflect 
the impact of H and L chains ratio on IgG folding and assembly. The IgG expression data 
collected from different bicistronic constructs showed that when the relative translation efficiency 
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of the IRES variant is higher than 0,4, IgG production levels increased rapidly. When the relative 
translation efficiency reaches to 0,5, IgG expression levels are nearly in the optimal status (Fig. 
27). The expression levels obtained were not increased, in the contrary, slightly reduced when 
using a more efficient IRES variant leading to a higher HC:LC ratio. 
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Figure 27 Effect of the ratio of translation efficiency of HC:LC on IgG production. The IgG 
was transiently expressed in HEK 293T cell with bicistronic vectors, the IgG 
concentration in the supernatant was determined by ELISA. The L chain was positioned 
as first cistron and translated under a cap-dependent mechanism; the H chain was 
positioned as second cistron and translated under IRES-driven internal initiation 
mechanism. The IRES mediated relative translation efficiency was determined in 
bicistronic constructs, which encodes the IgG L chain and an YFP reporter gene 
respectively in inverse cistron arrangement. The YFP fluorescence was analysed using 
flow cytometry. The relative translation efficiency of HC:LC ratio was derived from the 
relative translation efficiency of IRES variants compared to cap-dependent translation 
efficiency (I am very grateful to Congcong Zhang, for his help on acquiring of the raw 
data during his master thesis work)    
3.7 IgG purification 
Having validated a bicistronic expression system on the production levels, it had to be confirmed 
that the produced material is fully functional IgG. Supernatant from a CHO-K1 cell clone stably 
transfected with pDH1-IIB6 or from transiently transfected 293T cells was subjected to affinity 
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chromatography on protein A. The purified IgG antibody was analyzed by SDS-PAGE under 
reducing and non-reducing conditions (Fig. 28). Under reducing conditions, the about 50 kD 
heavy chain and the about 25 kD light chains appear close to the theoretical size of the chains 
based on its DNA sequence. Under non-reducing conditions, a higher molecular weight band with 
an apparent molecular mass higher than 250 kD is stained. Free light or heavy chain could not be 
detected. This indicates that the antibody chains are assembled into whole IgG molecule.  
 
Figure 28 SDS-PAGE and Coomassie staining of the purified human anti-MUC1 IgG. The 
IgG was produced from a stably transfected CHO-K1 clone with the pDH1 bicistronic 
vector, purified using affinity chromatography on protein A column. The antibody 
concentration was about 0,3 mg/L determined by Bradford assay. 
3.8 Analytical gel-filtration 
Analytical gel-filtration of purified IgG1 from transiently transfected HEK293T and stably 
transfected CHO-K1 cells were performed on a superdex-200 column. It showed that the IgG 
molecules from transiently transfected HEK293T cells were presented as IgG monomers, no 
aggregates were detected, however the IgG molecules from stably transfected CHO-K1 cells 
were present mainly as IgG monomer, some IgG dimers aggregates were formed (Fig. 29). This 
might reflect the subtle difference of protein intracellular modification and maturation in different 
host cells. The difference between the protein sample migrations on the non-reducing 
SDS-PAGE and size exclution gel filtration could be attributed to IgG being highly structured 
heterotetramers under non-reducing conditions, which may impact the migration rate compared 
to the denatured polypeptide. In addition, N-terminal sequencing of the purified IgG1 H chain and 
lambda L chain confirmed that the antibody expressed from the EMCV-IRES mediated bicistronic 
vector was processed accurately by correct cleavage of both heavy and light chain signal 
peptide.  
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Figure 29 Analytical gel-filtration of the human IgG produced from the pDH1 bicistronic 
vector on a superdex-200 column. A, the purified IgG produced from transiently 
transfected HEK293T cells with a concentration of about 1mg/ml. B, the purified IgG 
produced from stably transfected CHO-K1 cells with a concentration of about 0,3mg/L. 
For both, a 0,5 mL sample was injected.  
3.9 Characterization of human anti-MUC1 IgG  
3.9.1 Peptide ELISA 
 
To test the human anti-MUC1 IgG binding specificity, a peptide ELISA was performed on a 
16-mer MUC1 peptide antigen, a synthesized STAT3 peptide and BSA were used as control. The 
purified IgG and scFv both bind specifically to the MUC1 peptide; no unspecific binding to the 
control STAT3 peptide antigen and BSA was detected. However the binding activity of the IgG to 
the MUC1 peptide is about 20-30 times lower than of the scFv, which was derived from. The 
OD450 nm of 300 nM IgG corresponds to 9,4 nM scFv (Fig. 30).  
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Figure 30 Specificity test of human anti-MUC1 IgG and scFv using peptide ELISA. 1µg/well 
peptide antigen and BSA control were coated on Nunc Max 96-well microtiter plate at 
4°C overnight, the purified IgG and scFv with different dilution were loaded and 
incubated at RT for 1-2 hours, mouse anti-human or mouse anti-pentahis were added as 
secondary antibody with appropreate dilution and detected with POD conjugated 
anti-mouse antibody.  
 
3.9.2 Western-blot on cell lysates 
 
A human breast cancer derived T47D cell line was lysed and subjected to 6% SDS-PAGE, Jurkat 
lymphoma T cells lysates served as negative control. The seperated samples were transferred to 
a PVDF membrane, and the purified scFv and IgG were used to stain the MUC1 antigen 
respectively. MUC1 is a large, transmembrane glycoprotein, expressed at the apical surface of a 
variety of reproductive tract epithelia with a variable number of tandem repeat of 20 amino acids 
in its extracellular domain (Fig. 8). The binding signal of both IgG and scFv to cell lysates of T47D 
cells appeared to be a characteristic smear of high molecular weight bands as previously 
reported (Walsh, Luckie et al. 2000; Toleiks 2003), which was not found on Jurkat cell lysates 
(Fig. 31). The IgG gave a stronger binding signal than the scFv when an equal amount of 
antibodies was used to stain the PVDF membrane.  
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Figure 31 Western-blot analysis anti-MUC1 antibodies on cell lysate of T47D and Jurkat cells. 
107 T47D and Jurkat cells were lysed in 200µL lysis buffer, 10µL of the cell lysates were 
mixed with 5 x Laemmli sample buffer and denatured at 95°C for 10min and subjected to 6% 
SDS-PAGE. The separated protein samples were blotted on a PVDF membrane, stained 
with purified anti-MUC1 scFv and IgG and detected with alkaline phosphotase conjugated 
antibodies. The membrane was developed using NBT/BICP substrate. 
 
3.9.3 Flow cytometry analysis of binding to living cells 
 
FACS analysis of the binding specificity to living cells was performed using T47D and jurkat cells. 
Following incubation of the cells with 5, 25, 50 and 100 µg IgG, or 5 and 10 µg scFv antibodies 
respectively, a mouse anti-human and a mouse anti-penta-his monoclonal antibodies were used 
as secondary antibody respectively, and the cells were detected with FITC conjugated goat 
anti-mouse polyclonal antibody. Samples were analyzed by flow cytometry (FACSCalibur with 
CellQuest pro software). 30000 to 50000 total events were collected. Data was analyzed using 
the software WinMDI 2.8. The living cell subset was gated within the total forward-side scatter dot 
plots. Both IgG and scFv bound specially to T47D cells but not to Jurkat cells (Fig. 32 A).  For 
the IgG, the median of the fluorescence intensity was increased with the increasing amounts of 
antibody up to 100 µg for staining of 106 T47D cells (Fig. 32 B). When an equal molar amount of 
anti-MUC1 antibodies was used to stain the cells, the IgG gave a higher fluorescence intensity 
signal than the scFv (Fig. 32 B).    
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Figure 32 Flow cytometry analysis of the anti-MUC1 antibodies binding to T47D and jurkat cells. 
(A) Similar molar amounts of purified human anti-MUC1 scFv (10 µg) and IgG (50 µg) were 
used to stain T47D and Jurkat cells, positive binding to cells were detected by FITC 
conjugated antibodies. Data was collected by flow cytometry, diagram was obtained by using 
WinMDI 2.8 software. (B) The median of the fluorescence intensity of the anti-MUC1 IgG and 
scFv stained T47D cells. T47D cells were stained with different amounts of the human 
anti-MUC1 IgG and scFv and the binding to cells was detected by FITC conjugated 
antibodies. Data was collected by flow cytometry, Median of the gated cells fluorescence was 
obtained by using WinMDI 2.8 software. 
 
3.9.4 Surface plasmon resonance (SPR) analysis  
 
To determine the affinity of the IgG antibody to the synthesized MUC1 peptide, SPR analysis with 
a Biacore X was used to analyze the antibody-peptide interaction. The binding curves obtained 
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using concentrations of purified IgG from 6nM to 6µM (Fig 33A) were analyzed assuming a one to 
one interaction influenced by baseline drifting and bivalent analyte. The bivalent analyte model 
could be appropreate since the IgG is a bivalent analyte, although the coupled MUC1 peptide 
antigen “454* NH2-APDT(GalNAC)RPAPGSTAPPAC-COOH” glycopeptide offers only one 
binding site “XRPAP”. The residuals obtained for the one to one reaction with drifting base line 
was lower than the residuals obtained with bivalent analyte reaction model (Fig. 33 B, C). The 
parameter values calculated for the one to one reaction with base line drifting appeared 
reasonable. The binding affinity of the IgG KD (M) was found to be 3,90x10e-6 (Chi2: 0,583). 
Surprisingly, the value is about 15-20-fold lower than the scFv measured by Dr. Toleiks in his 
doctoral work using Biacore 2000, where KA (1/M) is 4,38x10e-6 and KD (M) is 2,28x10e-7.  
 
A 
B 
C 
Figure 33 Surface plasmon resonance (SPR) analysis of the IgG antibody on MUC1 peptide. (A) 
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Response curves obtained during and after injection of IgG on a surface coupled with 16-mer 
MUC1 glycopeptides. Resdual plots obtained in data analysis using interaction model 
corresponding to: (B) one to one reaction with drifting baseline; (C) a bivalent analyate. 
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IgG is a heterotetrameric glycoprotein with two identical L chains and two identical H chains. To 
produce IgG in mammalian cells, both H and L chain have to be synthesized in a single cell. The 
secretion competence, the stability and the rate of synthesis of the two chains are different, but 
the production levels of IgG are dependent on finally secreted heterotetrameric protein. Therefore, 
a balanced expression of both chains is essential for high-level production of mature IgG in 
mammalian cells. To increase IgG expression, numerous studies have been done, including 
cotransfection of two monocistronic constructs containing H and L chain expression cassettes, 
fusion of the cells expressing H and L chain respectively (Norderhaug, Johansen et al. 2002), 
modification of the selection marker (Allison A. Bianchi 2003; Sautter and Enenkel 2005), 
construction of bicistronic vectors (Jostock, Vanhove et al. 2004) and construction of one vector 
containing two promoters to drive H and L chain transcription respectively. The commonly used 
cotransfection of two monocistronic constructs is thought to be an inefficient procedure 
(Fussenegger, Bailey et al. 1999). The use of one vector with two identical promoters for stable 
expression bears a certain risk of recombination events. If two different promoters are used in 
one vector, highly unbalanced expression of both chains may take place. Internal ribosome entry 
sites (IRES) allow the co-expression of multiple polypeptide chains from the same mRNA. The 
EMCV IRES element was shown to be least affected by the flanking coding sequences and the 
mediated translation is accurate using both reticulocyte lysate translation extracts and cultured 
cells (Borman, Deliat et al. 1994; Borman, Bailly et al. 1995; Borman, Le Mercier et al. 1997; 
Hennecke, Kwissa et al. 2001). Therefore it seems to be the best choice for driving heterologous 
gene expression when compared to other picornavirus IRES. However, it was believed that, in 
most cases, the cistrons downstream of IRES are much less efficiently translated than the cistron 
following the promoter (Kaufman, Davies et al. 1991; Houdebine and Attal 1999), which limited a 
broadly use of polycistronic expression vectors for production of oligomeric proteins. In this study, 
a series of mammalian expression vectors for the production of recombinant IgG antibodies with 
different expression cassette designs were constructed to assess the influence of the promoter, 
cistron arrangement as well as the effect of H to L chain ratios on monoclonal antibodies (Mab) 
production in mammalian cells. The antibody expression levels from different vectors were 
evaluated in transiently and stably transfected cells. All the vectors constructed could be used to 
rapidly shuttle phage display derived antibody variable genes.  
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4.1 The impact of H and L chain on the reporter gene expression 
The properly folding and assembly of H and L chain in the endoplasmic reticulum plays important 
role in the biosynthesis of secretory IgG with full biological activity. It relies on chaperone systems 
in the ER that monitor and assist in the folding process (Knittler, Dirks et al. 1995; Trombetta and 
Parodi 2003). To analyze the impact of H or L chain in a bicistronic construct on the expression of 
the other cistron, a variant of the YFP gene (Venus) was used as reporter to speed up and 
simplify the evaluation. The Venus variant was shown to be a stable fluorescence marker gene 
for cell biological use with fast and efficient maturation (Nagai, Ibata et al. 2002). 
It shows that the H and L chain did not apparently affect YFP expression from the other cistron in 
the EMCV IRES containing bicistronic constructs in transiently transfected 293T cells (Fig. 12) . 
In contrast, in pooled stable CHO-K1 transfectants, the first cistron YFP expression from a setup 
with L chain as second cistron (pDYIL) gave a two times stronger signal compared to the design 
with H chain as second cistron (pDYIH) (Fig. 13). One explanation could be that the transcripts 
from the bicistronic setup pDYIL is shorter than from pDYIH, therefore, the cells transfected with 
pDYIL have a relative faster recycling of the machinery for transcription and translation than 
transfected with pDYIH. Therefore pDYIL might be more optimal for reporter gene expression in 
stably transfected CHO-K1 cells. Another explanation could be that the accumulated H chain is 
toxic to the cells (Wabl and Steinberg 1982). However, these explanations were not supported by 
the bicistronic constructs with inverse cistron arrangement in pooled stably transfected CHO-K1 
cells. There, at three days after selection, the mean fluorescence intensity yielded from pDLIY 
was in the same range as from pDHIY. 35 days after selection, the signal from pDLIY is even 
lower than pDHIY. The toxicity explanation might be excluded since the setup with H chain as first 
cistron and YFP as second cistron (pDHIY) gave a relative higher H polypeptide intracellular 
expression level than pDYIH, so that the intracellular accumulation of H chain polypeptide should 
be higher. However, the YFP signal was not decreased compared to the setup of pDLIY with L 
chain as first cistron. It might be argued that cap-dependent translation was affected by EMCV 
IRES mediated downstream cistron expression and that this is related the sequence of the 
downstream cistron. EMCV mediated H chain translation could exert stronger negative effects to 
upstream cap-dependent translation than L chian. In contrast to previous reports that the mRNA 
sequence can negatively affect on IRES mediated translation (Hennecke, Kwissa et al. 2001), the 
result in this study shows that the EMCV IRES mediated translation was not affected by the 
mRNA assembly in transiently transfected 293T cells and stably transfected CHO-K1 cells. The 
setup with H chain as first cistron and L chain as second cistron seems to be more optimal for IgG 
mammalian expression in a biscistronic construct. If this implication resulted from YFP reporter 
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gene analysis could be extended to mammalian IgG expression still need further confirmation. 
The difference between transiently transfected HEK 293T and stably transfected CHO-K1 cells 
could also due to cellular transacting factors needed for IRES activity. Many transacting factors 
have been found to be important in modulating IRES activity, however, there was no single 
protein been identified that is essential for the function of every IRES (Racaniello 2001). It was 
supposed that certain types of IRES have different requirements for cellular proteins. Different 
types of cells might provide different transacting factors. These integrative factors might affect 
YFP reporter gene expression. 
The relative translation efficiency of EMCV IRES compared to cap-dependent translation was 
evaluated in polycistronic vectors with inverse cistron arrangement. In the bicistronic constructs 
with the YFP reporter gene as first or second cistron, the cap-dependent translated YFP gene 
expression was about 2-5 times higher than the downstream IRES mediated YFP expression 
from the same vector with inverse cistron arrangement (Fig. 12, 13). The YFP expression from 
the 3rd cistron of the tricistronic vector with IgG L and H chian as first and second cistron was as 
efficient as from the second cistron of a bicistronic vector.  
Most IRES mediated bicistronic vectors so far incorporated an IRES downstream of a product 
and upstream of a selectable marker coding regions or a reporter fluoresence gene (Kaufman, 
Davies et al. 1991; Davies and Kaufman 1992). It was thought that the downstream gene 
expression in many cases was shown to be adversely affected by the gene positioned upstream 
of the IRES. The data in this study suggest that for Mab expression in mammalian cells, the H or 
the L chain that was positioned at upstream of IRES did not affect much the downstream cistron 
YFP gene expression in commonly used HEK 293T and CHO-K1 cell lines. 
4.2 The impact of different vectors designs on recombinant IgG expression. 
To make a commparative analysis of different vector designs on recombinant IgG mammalian 
expression, a series of monocistronic and bicistronic vectors was constructed (Fig. 14) and 
evaluated in transiently transfected HEK 293T and CHO-K1 cells. In transient expression, when 
an equal number of cells were transfected with an equal amount of plasmid DNA, the affection of 
copy number in single cells on IgG expression levels could be excluded using a large amount of 
cells so that small probability events should be neglected in the large population. Affection to the 
results by different transfection efficiencies could be excluded by multiple repeats of the 
experiment. Therefore, the result from transient transfection should reflect the performance of 
different vector designs on gene of interest transcription and translation as well as the following 
polypetide folding and assembly.  
 47
4 Discussion 
In the cotransfection with two monocistronic H chain and L chain expression plasmids (Fig. 15), 
the EF1-α promoter was shown to be more efficient than the CMV promoter. IgG expression 
levels were increased when the constructs with EF1-α promoter were used. Enhancement of H 
chain expression by using the strong EF1-α promoter seems to be more optimal for IgG 
expression than enhancement of the light chain expression with the strong promoter. The most 
optimal yield was obtained from cotransfection with two constructs both driven by EF1-α promoter. 
These may be explained by the fact that the expression of the L chain is more efficient than of the 
H chain when both H and L chains were driven by an identical promoter. At this situation, the 
intracellular H chain polypeptide does not saturate the capacity of L chain for IgG folding and 
assembly. When the EF1-α promoter drove both H and L chain, the total amount of intracellular H 
and L chain polypeptide is increased. However there may still be excess L chain polypeptide left, 
being secreted as monomer or homodimer, or being degraded.  
The bicistronic expression constructs yielded expression levels in the same range as the 
cotransfected monocistronic expression constructs (Fig. 15). The setup with L chain as first 
cistron driven by EF1-α was better by a factor of 2 compared to the design with H chain as first 
cistron. In the CMV promoter driven bicistronic constructs pDH1 and pDL1, no apparent affection 
was detected from the different cistron arrangements of H chain and L chain. The translation 
initiation efficiency of the IRES variant used in these bicistronic constructs is about 3 times lower 
compared to cap-dependent translation initiation. Therefore, when the cistron arrangement was 
H-IRES-L, the relative ratio of H and L chain translation efficiencies HC:LC should be around 3:1; 
when the cistron arrangement was L-IRES-H the relative ratio of H and L chain translation 
efficiencies HC:LC should be around of 1:3. It was reported that the expression of L chain is 
about 1,5-2 times more efficient than H chain in transiently transfected cells (Schlatter, Stansfield 
et al. 2005) and the excess of intracellular L chain is more optimal for IgG mammalian expression 
(Gonzalez, Andrews et al. 2002; Schlatter, Stansfield et al. 2005). The result in this study shows 
that bicistronic mammalian expression with an excess of H chain or L chain could give similar IgG 
yields in transient expression. One possibility could be that the ratio of H and L chain expression 
from both bicistronic vectors are not in the optimal range. The capacity of L chain driven IgG 
folding and assembly from transfectants of pDL1 was limited by the expression levels of H chain. 
In the case of pDH1, the L chain expression levels should be lower than from pDL1. Therefore, 
the capability of the L chain driven IgG folding and assembly was lowered, however, an excess of 
H chain peptide in the ER could lead to more efficient usage of L chain. This might cause the cells 
transfected with the two bicistronic constructs respectively to give IgG yields in the same range, 
which indicates that H chain might also play an important role on IgG folding and assembly. 
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One of the most important criteria for successful generation of a recombinant protein from a 
recombinant cell is to obtain a cell line that maintains stability of production. The stable 
expression of foreign gene in mammalian cells must be established in the context of the nucleus 
and is associated with numerous transacting factors. The expression of an integrated gene in 
either tissue culture or transgenic animals is influenced by the proximity of host heterochromatin, 
which was conferred to “position effect” of gene expression in mammalian cells (Singh 1994). 
Stable genes of interest expression must maintain an appropriate status in chromatin in the 
systems designed for long-term production. These are usually obtained by screening a large 
amount of clones. In this study, 15 monoclonal stably transfected CHO cell lines were randomly 
selected, the prevalence of positive clones and antibody expression levels of bicistronic vectors 
expression are in the same range as monocistronic expression (Fig. 16). However, cotransfection 
of the two monocistronic in transiently transfected 293T and CHO-K1 cells gave about two times 
higher expression levels than the bicistronic vectors used (Fig. 15). This indicates that the site of 
integration plays dominant role on stable recombinant IgG expression. Similar to the results from 
transient expression, no apparent difference was found between H-IRES-L and L-IRES-H citron 
arrangements. A previous report showed that for stable expression in CHO cells, expression 
vectors biased toward low HC:LC polypeptide ratios (<1:2) are likely to generate a greater 
proportion of cell clones with elevated Mab expression levels in pools of primary transfectants 
(Schlatter, Stansfield et al. 2005). A high intracellular HC polypeptide concentration could 
produce ER stress and deleterious effects on cell function which slow down IgG folding and 
assembly in ER (Lenny and Green 1991; Gonzalez, Andrews et al. 2002). The results in this 
study might have a possibility that they were derived from clonal variability in transcriptional or 
translational processing of recombinant genes. Irrespective of the cause, together with the results 
from transiently transfected HEK 293T and CHO-K1 cells, it was found that bicistronic expression 
vectors with different cistron arrangement gave the same range of IgG yields. These findings 
allow the implication that for IgG expression in mammalian cells, when there is an excess of H 
chain polypeptide, IgG could be produced as efficient as when there is an excess of L chain. It 
was also reported that the assembly of multimeric protein complexes in the ER is not strictly 
dependent on the proper folding of individual subunits; rather, assembly can drive the complete 
folding of protein subunits (Lee, Brewer et al. 1999). Antibody expression and maturation without 
immunoglobulin L chain is feasible and H chain antibodies that can be secreted independently in 
some cases (Kirkpatrick, Ganguly et al. 1995; Nguyen, Zou et al. 2003). Therefore, for the design 
of stable expression vectors with enhanced IgG production, a comparative analysis of the excess 
of H or L chain should be performed. Further improvement of the expression vectors could help to 
reveal the underlying mechnism of H and L chain folding and assembly.  
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The causes of instability of production are varied and the exact molecular mechanisms are 
unclear. When a new gene element is induced to mediate recombinant protein expression, the 
affection on the stability should be studied. So far, reports of an affection of IRES elements on 
stability of recombinant protein production were not found. To test the long-term effect of the 
IRES element on Mab expression, a stable CHO cell lines were generated and analyzed for 
expression levels and stability over a period of 300 days (Fig. 17). The stability of IgG expression 
in CHO cells from a bicistronic vector is in the same range as documentation in a recent review 
for monocistronic expression (Barnes, Bentley et al. 2003). This indicates that the EMCV IRES is 
a suitable candidate for stable expression of IgG in CHO cells. It seems that the IRES did not 
stimulate more repulsion from host cells defense mechanism than other gene elements.  
It is known that long term storage, buffer composition and processing conditions can lead to the 
formation of soluble or insoluble IgG aggregates. The aggregation of IgG could affect the 
antibody–antigen binding. In analytical gel filtration studies, the recombinant IgG was found to be 
mainly exists as monomeric. No aggregates were detectable for IgG from transiently transfected 
HEK293T cells, however, a small fraction of dimeric aggregates were detected for IgG from in 
stably transfected CHO-K1 cells (Fig. 29). The difference is most likely due to the difference of 
glycosylation between HEK 293T and CHO-K1 cells; however, a methodological difference 
during the process of IgG production and the storage of the harvested supernatants cannot be 
excluded. 
4.3 The impact of the relative ratio of H and L chain on IgG transient expression 
The ratio of intracellular expression levels of H and L chain polypeptide in the ER is believed to 
be a crucial factor influencing the rate of folding and assembly (Gonzalez, Andrews et al. 2002). It 
is important to investigate the optimal ratio of HC:LC in the ER to develope optimal IgG 
expression vectors. Most studies about the impact of H and L chain ratios on IgG folding and 
assembly in mammalian cells were performed by cotransfection of two monocistronic H and L 
chain expression plasmid (Kaloff and Haas 1995; Lee, Brewer et al. 1999; Montano and Morrison 
2002; Schlatter, Stansfield et al. 2005). The discovery of internal ribosome entry sites (IRES) 
provided a new tool for co-expressing multiple polypeptide chains of oligomeric or oligosubunit 
proteins in polycistronic expression systems. To investigate the optimal ratio of HC:LC in the ER 
using bicistronic vectors, a series of IRES elements with a continuous range of relative translation 
efficiencies has to be obtained.  
A number of studies have shown the importance of both RNA secondary and tertiary structures in 
viral cap-independent translation (Jang and Wimmer 1990; Le, Chen et al. 1993; Haller and 
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Semler 1995; Wang 1995; Hoffman and Palmenberg 1996; Honda, Brown et al. 1996; Witwer, 
Rauscher et al. 2001). We made a mutational analysis of EMCV IRES, and a series of variants 
with relative translation efficiencies ranging from 0,03 to 0,6 compared to cap-dependent 
translation were obtained (Congcong Zhang’s master thesis). The IRES variants were used to 
study the impact of relative the ratio of H to L chain on IgG folding and assembly in bicistronic 
expression system. It was supposed that the IgG expression levels depend on the H chain 
expression levels in bicistronic expression vectors with the L chain as first cistron and H chain as 
second cistron since the IRES mediated cap-independent translation efficiency is lower than the 
cap-dependent translation efficiency. Promoter strength or local effect was avoided as the L 
chain and H chain are translated from the same mRNA. It should provide a more accurate 
method for the evaluation of the optimal ratio of HC:LC than adjustment of the amount of 
cotransfected H and L chain expression plasmids. The lgG expression levels are presumed to 
reflect the impact of the H and L chain ratio on IgG folding and maturation. It was found that an 
optimal IgG production was obtained when an IRES variant with a relative translation efficiency of 
50% compared to cap-dependent translation was used (Fig. 27). Therefore, it can be assumed 
that H chain and L chain translation efficiency was in the range of 1:2. Significantly, the IgG 
expression levels did not further increase, when a more efficient IRES variant was used. It was 
concluded that the IgG production reqires intracellular expression levels of HC:LC are in the 
range of 1:3 to 1:4 as transiently transfected cells synthesize the H chian is 1,5-2 times less 
efficient than of the L chain (Schlatter, Stansfield et al. 2005). Immunoblot analysis of intracellular 
H and L chain expression levels showed a similar result (Congcong Zhang’s master thesis). It 
was reported that when the HC: LC polypeptide ratio approaches unity, the Mab assembly time is 
increased (Gonzalez, Andrews et al. 2002). This could be used to explain that the IgG expression 
levels were not increased with increasing the relative H chain intracellular expression. In stably 
transfected CHO cells, a more efficient H chain expression should be needed to get an optimal 
IgG expression, since the L chain was shown to have a relatively higher intracellular expression 
in stably transfected cells than in transiently transfected cells (Schlatter, Stansfield et al. 2005). 
This study has focused on the impact of H chain on IgG production when L chain is in excess. It 
still needs to be studied what the impact of L chain would be when the H chain is in excess. By 
using bicistronic vectors with a series of IRES variant with different translation efficiencies, it 
provides a new method to investigate the IgG production in mammalian cells and to understand 
the underlying mechanism of IgG folding and assembly. 
4.4 The impact of S/MAR elements on IgG expression 
It was reported that the use of S/MAR-containing vectors improved transgene expression in a 
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divers set of cell lines (Agarwal, Austin et al. 1998; Bode, Benham et al. 2000; Kurre, Morris et al. 
2003). In this study, the bicistronic expression constructs with one or two S/MAR elements did not 
increase the IgG expression levels among around 50 randomly selected CHO-K1 clones (Fig. 22). 
However, the prevalence of positive clones was significantly increased using the construct with 
two S/MAR elements flanking the expression cassette (Fig. 21). This is partially inconsistent with 
a previous report where the S/MAR element apparently increased the prevalence of positive 
clones and the IgG expression levels in 15 randomly selected clones (Zahn-Zabal, Kobr et al. 
2001).  
The integration copy number of IgG expression cassettes was not compared in this study to see if 
it was in the same range for the plasmids with or without S/MAR element. This may be one of the 
reasons that the highest producer resulting from the vector without S/MAR element was much 
higher compared to all clones obtained with the vectors containing S/MARs. Although, according 
to recent reports, it seems that the S/MARs do not affect the copy number of integration 
significantly (Zahn-Zabal, Kobr et al. 2001; Heng, Goetze et al. 2004). The S/MAR enhanced 
gene expression was directly correlated with the number of transgenes associated with the 
nuclear matrix but not with the total number of transgenes integrated (Heng, Goetze et al. 2004). 
Therefore, it may be argued that for the events of single or low copy integration, the expression 
levels from constructs with S/MAR elements were enhanced, but for the multi-copy integration 
events, the augmentation induced by S/MARs might be slight if most of integrated expression 
cassettes are not directly correlated with the S/MAR elements. This might be the case in this 
study. In addition, an enhancement of expression levels of high producers by S/MAR elements 
was not reported so far.  
To explore an alternative method for IgG expression in mammalian cells and to make a 
comparative analysis with classic vectors, a supposed S/MAR element mediated episomal vector 
was constructed. The S/MAR element was placed downstream of a tricistronic expression 
cassette, encoding an IgG L chain and H chain as well as an YFP reporter protein, upstream of 
the BGH polyA signal (Fig. 23). The reporter gene expression levels were reduced in both 
transiently and stably transfected CHO cells compared to the reference vector (Fig. 24, 25 and 
Tab. 2). This is imaginable since polyadenylation is tightly involved in transcription, splicing and 
translation etc., the multiple steps process of gene expression (Proudfoot, Furger et al. 2002). 
When a 2,2kb S/MAR is placed between a transcript and a ploy A signal, at least, the 
transcription termination could be less efficient and the recycling of the transcription apparatus 
could be slowed down. Therefore the concentration and the stability of mRNA may be reduced, 
which leads to lower gene expression levels. Plasmid rescue experiments were not successful 
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and the H chain constant region could be PCR amplified using genomic DNA as template (Fig. 
26). It seems that the tricistronic plasmid with S/AMR was rather integrated than being replicated 
as an episome, although further experiments need to be done. 
In summary, S/MAR elements seem to be willing to help the “poor”, by increasing the prevalence 
of positive clones but did not give rise to the highest expression levels. When low levels and 
long-term stable expressions are desired, S/MARs may provide an apparent advantage. The 
relationship of S/MAR and “elite” producer is not clear although it was recently reported that 
chicken Lysozyme 5’ MAR is helpful to obtain higher expression levels (Girod, Zahn-Zabal et al. 
2005).  
4.5 The human anti-MUC1 IgG 
Unconjugated antibodies show significant efficacy in the treatment of breast cancer, 
non-Hodgkin’s lymphoma, and chronic lymphocytic leukemia. The success of antibody drugs like 
Herceptin and others has stimulated the US NIH to launch an ambitious project to search all 
alterations of major types of cancer. For a successful use of antibodies for immunotherapy, the 
choice of target antigen, the immunogenicity of antibodies and the plasma half-life of the antibody 
have to be considered carefully (White, Weaver et al. 2001). Human MUC1 is a type I 
transmembrane protein with a mucin-like ectodomain resulting from extensive glycosylation of 
the variable number tandem repeats (VNTR) (Brayman, Thathiah et al. 2004). Cancer-associated 
MUC1 is aberrantly overexpressed (10–40 fold) in a variety of cancers. It is incompletely 
glycosylated and as a result exposes internal sugar units and naked peptide sequences, which 
are cryptic in the normal mucin molecule. It has been shown to be a useful target for antibodies 
and cellular immunity, beneficial immune responses can be induced by MUC1 immunization 
(Gimmi, Morrison et al. 1996; Miles and Taylor-Papadimitriou 1998; von Mensdorff-Pouilly, 
Verstraeten et al. 2000; Taylor-Papadimitriou, Burchell et al. 2002; Agrawal and Longenecker 
2005).  
The human anti-MUC1 antibody IIB6 recognizes the tumor associated MUC1 antigen, and was 
confirmed to specifically bind to the VNTR with the liner epitope “XRPAP”. The MUC1 VNTRs are 
necessary for an ordered tertiary structure to modulate cell-cell and cell-extracellular matrix (ECM) 
interactions by steric hindrance of the extracellular domain (Wesseling, van der Valk et al. 1996; 
Komatsu, Carraway et al. 1997). Except the mechanical function, VNTRs are also important for 
intercellular adhesion molecule-1 (ICAM-1) recognition (Agrawal, Krantz et al. 1998; Kam, 
Regimbald et al. 1998), and a specific T cells response directed against an epitope of the human 
MUC1 VNTRs was found in 1990’s (Spicer, Rowse et al. 1995).  
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In this study, the phage-derived scFv IIB6 was converted to IgG and produced in mammalian 
cells. The scFv and IgG specifically bind to breast cancer derived T47D cells. The IgG showed a 
better binding signal in western blot on cell lysates and in FACS analysis of living T47D cells 
when an equal molar amount of IgG and scFv antibodies were used (Fig. 31, 32). In the western 
blot on the cell lysates both, scFv and IgG, showed a smear signal (Fig. 31). The VNT repeats of 
20 residues (PDTRPAPGSTAPPAHGVTSA) contain five threonines and serines that are all 
modified with mucin type O-linked glycans (Hanisch, Uhlenbruck et al. 1989; Hull, Bright et al. 
1989; Lloyd, Burchell et al. 1996) and this domain is flanked by imperfect repeats with fewer 
glycosylation sites. In addition to O-linked glycosylation, MUC1 contains five consensus sites for 
N-linked glycan addition in a nonrepetitive sequence adjacent to the single transmembrane 
domain. Therefore, the western blot signal of the aberrant glycosylated tumor associated MUC1 
from cancer cells appears to be a characteristic smear. The binding signal of the IIB6 human 
anti-MUC1 antibody indicates that the antibody binding capacity to the MUC1 antigen was not 
affected by the glycosylation. It was found that the aberrant intracellular localization of MUC1 in 
tumor cells correlates with an aggressive tumor and a poor prognosis for the patient. Usually, the 
highly extended ectodomain inhibit MUC1 internalization (Kinlough, Poland et al. 2004). The 
aberrant glycosylation could result in an altered endocytic trafficking and lead to subcellular 
redistribution of MUC1 in tumor cells (Altschuler, Kinlough et al. 2000). This shows that the IIB6 
antibody could be a promising candidate for immunotherapy of MUC1 antigen positive cancers. It 
could be used to prevent the metastasis of tumor cells and to develop targeted immunotoxins. 
Surprisingly, the relative MUC1 peptide antigen binding affinity of the IgG was found to be about 
20-fold less than that of the IIB6 scFv (Fig. 30). The affection of the IgG by aggregation was 
excluded after gel filtration analysis, which identified the IgG to be monomer (Fig. 29). The loss of 
binding affinity could be caused by post-translational modifications of the mammalian expression 
system, such as glycosylation, which might change the antigen binding properties of the phage 
display derived scFv. The scFv, which was selected from on E.Coli based screening system, 
might be folded differently from the IgG chains that are folded in the ER of mammalian cells with 
the cooperation of chaperones. Further, an affection of the linker connecting the V-domains of the 
scFv on the conformation of the binding site cannot be excluded. To investigate the phenomenon, 
analysis of mammalian expressed scFv formats of IIB6 would be helpful. In contrast to the 
peptide recognition, binding of the IgG to native MUC1 on T47D cells was as efficient as or more 
efficient than binding of the scFv. Probably, the surface of T47D cells has a high density of MUC1 
antigen leading to avidity effects, whereas in the peptide ELISA, the coating of the peptide 
antigen onto the microtitrer plate could be not efficient leading to a low antigen density. Finally, 
the density of the coated antigen could be too low for bivalent binding.   
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There are different views toward the effect of the antigen binding affinity on the antitumor efficacy 
of mAb therapeutics. The use of mAbs with higher relative affinity leads to a higher percentage of 
of mAb bound to tumor and it was thought to be a distinct therapeutic advantage (Schlom, 
Eggensperger et al. 1992). The need for a high-affinity antibody is dependent on the density of 
the target antigen. High-affinity antibodies bind effectively even with a single antigen-antibody 
interaction, irrespective of the antigen density. In contrast, low-affinity antibodies require the 
avidity conferred by di- or multi-valent binding for effective attachment, which can only occur if 
antigen density is above a certain threshold (Zuckier, Berkowitz et al. 2000).  
Studies have shown that adjuvant therapy for breast cancer may increase the chance of 
long-term survival by preventing a recurrence (Hortobagyi 2000). Adjuvant therapy has the goal 
to kill any cancer cells that may have spread, even if the spread cannot be detected by radiologic 
or laboratory tests. The use of an appropriate anti-MUC1 antibody might block adhesion between 
tumor cells and a possible new growing site and thus reduce the metastatic spread of tumor cells. 
High affinity of the anti-MUC1 IgG is desired in order to arrest the tumor cells in circulation and 
stop metastases. The human IgG IIB6 could be an alternative therapeutics for breast cancer 
adjuvant therapy and a potent tool to study the role of MUC1 on breast cancer tumor cells 
metastasis.  
4.6 Outlook 
Recombinant protein production in mammalian cells is a complex multistep process including 
gene transfer, integration, replication, transcription, translation, protein trafficking, polypeptide 
folding and assembly, secretion, producer screening, host cell growth and subsequent feeding 
(Fig. 34). Each step plays a crucial role for the final success of protein production. To obtain 
high-level protein production, an optimal process with a compromise of each step has to be 
established. The volumetric productivity of mammalian cells cultivated in bioreactors increased 
significantly over the past 20 years through the improvements in media composition and process 
control (Wurm 2004). There still is potential to increase the productivity of cells by controlling cell 
growth (Kaufmann and Fussenegger 2003). Host cell engineering will continue to be the most 
promising strategy for improvement of recombinant protein production. 
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Figure 34 Cell line generation and development for cell culture processes for the generation of 
recombinant proteins of interest. The wavy lines indicate subcultivations of individual cell 
lines that are in a screening program to obtain the final producer. Vials indicate banks of cells 
frozen in liquid nitrogen. Spinner flasks represent scale-down systems for process 
optimization, and bioreactors represent large-scale production processes. Reproduced from 
literature (Wurm 2004) 
There is little doubt that obtaining a cell line that maintains stability of production is one of the 
most important criteria for successful generation of a therapeutic protein from a mammalian cell. 
Stable cell lines were usually obtained by the integration of the gene of interest into the genome 
of a host cell. The most common method for achieving integration of recombinant genes into a 
host cell genome is by random insertion into chromosomes. In theory, the integrated genes would 
be passed onto daughter progeny and keep stable. However, instability of protein production is 
still a substantial problem for a selected stable integrated cell line. One of the causes of instability 
of production is the loss of gene of interest from the recombinant host cells’ genome, particularly 
for the CHO expression system (Pallavicini, DeTeresa et al. 1990; Kim SJ, Kim NS et al. 1998; 
Hammill L, Welles J et al. 2000.). The other causes maybe due to the appearance of 
nonproducting populations of cells, which often have a growth advantage over production 
populations, and hence lead to an overall decrease in production (Chuck and Palsson 1992; Bae, 
Hong et al. 1995). The appearance of nonproducing populations of cells can arise due to loss of 
gene copies and may also occur as a consequence of problems with transcription and/or 
subsequent steps of gene expression (Barnes, Bentley et al. 2003). It is generally accepted that 
the site of integration into the chromosome has dominant effect on the recombinant gene 
expression in eukaryotic cells (Wilson, Bellen et al. 1990). The position effect can be caused by 
gene rearrangement or incorporation of recombinant genes into regions with nearby endogenous 
promoters or enhancers, or areas of heterochromatin (Barnes, Bentley et al. 2003). Modification 
of the host cells may provide opportunities to increase the stability as well as the expression 
levels for recombinant protein production. Various DNA elements, including insulators, LCR, 
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S/MAR and ubiquitous chromatin opening elements (UCOEs) etc, have been discovered, which 
can modulate the position effect and hence may be important in controlling expression levels and 
stability of protein production. They mostly function through remodeling the local chromosome 
structure by enabling the binding of proteins and thus either enhance or inhibit the effect of the 
surrounding chromatin on specific genes (Agarwal, Austin et al. 1998; Bode, Benham et al. 2000; 
Kurre, Morris et al. 2003). Using these elements may pave a way to obtain a stable cell line with 
enhanced stability and high recombinant gene expression levels. However, the underlying 
mechanisms of the function of these elements are far from clear. More work need to be done to 
understand and make use of these elements for recombinant gene expression in mammalian 
cells. A detailed studying of a high producer may help to understand the requirements of 
high-level stable expression of recombinant genes and the interaction of foreign genes with 
surrounding genomic regions. With the accelerated advancing in technology, such as whole 
genome sequencing, genome-scale high-throughput screening, studying the interaction of 
biological macromolecules in real time and in living cells, new scientific breakthroughs are 
possible. As we move to the "postgenomic" era, more and more gene products and the way in 
which they are regulated become well understood. Host cells may be modified as something like 
a assemble line for protein of interest production. It might include depressing position effect, 
reducing silencing modification, and enhancement of the recycling of transcription, translation 
machinery, smoothing the way for polypeptide folding and assembly.     
Further promising methods are to improve the gene transfer efficiency or optimize the 
recombinant gene replication status. The commonly used random integration into chromosome 
procedure is very inefficient (Gorman and Bullock 2000) and the site of integration, the number of 
copies integrated, and the level of expression cannot be predicted. The use of episomal vectors 
might be an alternative method for protein production in eukaryotic cells (Baiker, Maercker et al. 
2000; Bode, Fetzer et al. 2001). However, at present the mechanism of nonviral episomal vectors 
replication is not clear and still far from practical use for recombinant protein production (Jenke, 
Fetzer et al. 2002; Antequera 2004; Jenke, Stehle et al. 2004; Jackson 2005). One of the most 
practical methods is the targeted integration of the transgenes into the sites that are thought to be 
relevant for high expression (Bode, Schlake et al. 2000; Gorman and Bullock 2000). Among 
these techniques, the recombinase-mediated cassette exchange (RMCE) is a very promising 
method, which enables a double-reciprocal crossover reaction by mutation of target sequences 
(Baer and Bode 2001). It is a potent tool for scientific research and a method containing huge 
commercial value. So far, successful RMCE was mostly reported in ES cell. There are few 
confirmed reports for the industrial production commonly used CHO, BHK or NSO cells. 
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Nevertheless, even when the RMCE efficiency is improved for practical use more detailed 
information is needed to be collected between the successful RMCE and real production.  
The H and L chain folding and assembly is a crucial step for IgG production in mammalian cells. It 
is affected by the ratio of HC:LC intracellular expression levels. Therefore, it is crucial to 
investigate the optimal ratio of HC:LC for IgG production. Although there are some reports on this 
topic (Kaloff and Haas 1995; Gonzalez, Andrews et al. 2002; Schlatter, Stansfield et al. 2005), it 
would be a helpful guideline for IgG production, if a delicate model of HC:LC folding and 
assembly is established. 
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5.1 Materials 
5.1.1 E.coli strain 
XL1-Blue MRF´ Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 
supE44 thi-1 recA1 gyrA96 relA1 lac [F´ proAB 
lacIqZΔM15 Tn10 (Tetr)]. 
Stratagene, La 
Jolla, USA 
DH5αTM F- 80dlacZ M15 (lacZYA-argF) U169 recA1 
endA1 hsdR17(rk-, mk+) phoA supE44 - thi-1 gyrA96 
relA1 
Invitrogen, La Jolla, 
USA 
K12 GM2163 F- dam-13::Tn 9 dcm-6 hsdR2 leuB6 his-4 thi-1 
ara-14 lacY1 galK2 galT22 xyl-5 mtl-1 rpsL136 
tonA31 tsx-78 supE44 McrA- McrB-  
NEB, UK 
 
5.1.2 Eukaryotic cells 
Cells Culture medium Source 
CHO-K1 Ham's F12/DMEM + 2mM Glutamine + 10% 
Foetal Calf Serum (FCS) 
ECACC No. 85051005 
293T DMEM + 2 mM L-glutamine +1.5 g/L sodium 
bicarbonate and 4.5 g/L glucose + 10%FCS  
ATCC No: CRL-11268 
Jurkat E6.1 RPMI 1640 + 2mM Glutamine + 10% FCS ECACC No. 88042803 
T47D DMEM + 2mM Glutamine + 10% FCS ECACC No. 85102201 
 
5.1.3 Chemicals, solvents and enzymes 
The commonly used chemicals and solvents were from Fluka (steoheim, Germany), Merck 
(Darmstadt, Germany), or Carl Roth (Karlsruhe Germany). Enzymes were from NEB, MB 
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fermantas, Promaga. Monoclonal antibodies, enzyme conjugated antibodies and fluorescence 
conjugated antibodies were from Sigma (Steinheim, Germany).  
5.1.4 Materials for electrophoresis 
1 kb and 100 bp DNA ladder Fermentas, Stuttgart 
Ethidium bromide Roche Diagnostic, Penzberg 
Precision plus protein standard, dual color Bio-Rad, Hercules, CA,USA 
Precision plus protein standard, unstained Bio-Rad, Hercules, CA,USA 
Acrylamide solution 30 % Roth, Karlsruhe 
APS Sigma, Deisenhofen 
BCIP Roth, Karlsruhe 
NBT Roth, Karlsruhe 
TEMED Sigma, Deisenhofen 
5.1.5 Materials for cell culture and storage  
RPMI 1640 PAA LabGmbH, Parsing Austria 
DMEM PAA LabGmbH, Parsing Austria 
DMEM/F12 PAA LabGmbH, Parsing Austria 
Trypsin/EDTA PAA LabGmbH, Parsing Austria 
Foetal bovine serum (FCS) PAA LabGmbH, Parsing Austria 
Bacto tryptone  BD, Sparks, USA 
Bacto yeast extract BD, Sparks, USA 
DMSO Roth, Karlsruhe 
 
5.1.6 Equipments 
Biofuge pico 
Centrifuge 5415 D 
Heraeus-Christ,  
Eppendorf  
Centrifuge 5810R Eppendorf 
Multi fuge 3 S-R Heraeus 
Centrifuge 
Sorvall RC 5 (SS34, GS-3 and 
SLA3000) 
Sorvall 
   
Electroporation 
apparatus 
Gene Pulser II, Pulse Controller BioRad, Hercules, CA, USA 
   
Libra S11 Biochrom, U.K. UV/Visible 
spectrophotometer Ultrospec 3100 pro Amersham Pharmacia  
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Electrophoresis power supply 
EPS 601/301 
Amersham, Uppsala, Sweden 
Mini protean 3 cell BioRad, Hercules, CA, USA 
Semi-dry transfer cell BioRad, Hercules, CA, USA 
Electrophoresis 
apparatus 
Gel dryer model 543 BioRad, Hercules, CA, USA 
   
Dialysis Tubing Visking Servapor and Membra-cel 
Äkta prime Amersham, Uppsala, Sweden 
1mL Protein A column Amersham, Uppsala, Sweden 
1mL HisTrap HP Amersham, Uppsala, Sweden 
Protein purification 
apparatus  
Superdex 200 HR 10/30 Amersham, Uppsala, Sweden 
   
Thermomixer compact Eppendorf 
Vortex genie 2 Scientific industries, Bohemia N.Y. 
Mixer 
Platform rocker Str6 Bibby stnart, UK 
   
Millipore ultrafiltration 
membranes 
Amicon bioseprations, Molsheim, 
France 
Cellulose acetate filter:  
0,2 μm, 0,45 μm 
Sartorius AG, Goettingen 
Whatman filterpaper Whatman, England 
Arium 611 Sartorius AG, Goettingen 
Filter apparatus 
Reusable bottle top fliter unit Nalge company 
   
Clean bench Lamiair HLB 2472 Heraeus  
   
Shaker Certomat BS-1 B.Braun Biotech international 
   
Squencer A&B Applied Biosystems, 
ABI prism 310 collection. 
Perkin-Elmer, Applera  
   
FACS FACScan  
FACSCalibur 
Becton Dickinson, San Jose, USA 
Becton Dickinson, San Jose, USA 
   
PCR machine PTC200 peltier thermoral cycler MJ Research 
   
Freezer 4°C, -20°C and –80°C Lieberherr, Hera Freeze 
5.1.7 Kits for DNA purification and transfection 
GFX PCR DNA and gel band purification kit Amersham, Uppsala, Sweden 
GFX micro plasmid prep kit Amersham, Uppsala, Sweden 
Plasmid DNA purification kit Macherey-Nagel, Germany 
Genelute HP plasmid midiprep kit Sigma-Aldrich, Steinheim 
Lipofectamine 2000 Invitrogen, Karlsruhe 
HEKFectin Bio-Rad, Hercules, CA 
TransFectin Lipid reagent Bio-Rad, Hercules, CA 
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5.1.8 Buffer and solutions 
0,5M EDTA (Disodium Ethylene 
Diamine Tetra-Actate, pH8,0) 
Add 181,6 g Na2EDTA.2H2O to 800 mL ddH2O, 
adjust to pH8,0, make up to 1 litre with ddH2O, 
sterilized by autoclaving. (Note: EDTA is only 
soluable in basic pH) 
Phosphate Buffered Saline (PBS) 
pH7,2-7,4 
137 mM NaCl, 2,7 mM KCl, 10 mM Na2PO4, 2 mM 
KH2PO4. 
50x TAE buffer 2 M Tris base, 1 M acetate, 100 mM EDTA. 
10x non-denaturing Gel running buffer Dissolve 30,3 g of Tris-base, 144,2 g of glycine in 
800 mL ddH2O, adjust the pH to 8,3, make up to 1 
litre with ddH2O. 
10 x Laemmli Running buffer Dissolve 30,3 g of Tris-base, 144,2 g of glycine, 10 g 
of SDS in 800 mL ddH2O, after all the chemicals 
have dissolved, make up to 1 litre with ddH2O. 
5x SDS-PAGE (Hart and Laemmli) 
sample buffer 
0,312 M Tris-HCl pH6,8; 10%SDS; 25% 
β-mercaptoethnol; 0,05% bromophenol blue.  
Staining proteins on Acrylamide 
(Coomassie Brilliant Blue (CBB)) 
Dissolve 2,5 g Coomassie Brilliant Blue R250 in 450 
mL ddH2O, add 450 mL methanol and 100 mL 
glacial acid, flirter the solution a Whatman #1 filter 
paper to remove particulate matter.   
Destaining buffer for CBB stained Gels To 1-liter glass flask, add 250 mL methnol and 70 
mL glacial acetic acid, adjust the volume to 1 liter 
with H2O. Store at room temperature.  
BCIP Dissolve 0,5 g of 5-brmo-4-chloro-3-indolyl 
phosphate disodium salt in 10 mL of 100% 
dimethyfomamide, store at 4°C. 
Nitroblue Tetrazolium (NBT) Dissolve 0,5 g of nitroblue tetrazolium chloride in 10 
mL 70% dimethylformamide 
NBT/BCIP reaction buffer Add 66 μL of NBT stock and 33 μL of BCIP stock to 
10mL alkaline phosphatase buffer. Substrate should 
be used within 30 min. 
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Ampicillin (Amp) 100mg/mL  Dissolve 1 g of sodium ampicillin (sodium salt. 
m.w.=371,40) in sufficient H2O to make a final 
volume of 10 mL. Dispense to 1 mL aliquots, store at 
–20°C. Working concentration: 100 μg/mL 
Kanamycin (Km) (10-50mg/mL) Dissolve 100-500 mg kanamycin monosulfate 
(m.w.=582,60) in sufficient H2O to make a final 
volume of 10 mL. Divide into 1 mL aliquots and store 
at –20°C. Working concentration:10-50 μg/mL  
5.1.9 Protease inhibitors 
Inhibitor Protease target Working concentration Stock solution 
Aprotinin Serine protease 5 μg/mL 1 mg/mL in PBS 
Leupeptin Serine and thiol protease 5 μg/mL 1 mg/mL in H2O 
Pepstatin  Acid protease 5 μg/mL 1 mg/mL in methanol 
EDTA metalloprotease 0,5-2 mM 0,5 M in H2O pH8,0 
PMSF  Serine protease 1 mM 100 mM in isopropanol 
5.1.10 Oligo-nucleotide primers 
Jl215-PstI-f1 5’-CATGGCGCAAGTTCAGCTGCAG-3’ 
Jl215-NheI-r1 5’-GTCCGCTAGCTGAGGATACGGTGACCGTGG-3’ 
Jl215-SacI-f1 5’-TATCGAGCTCACCCAATCTCCACTCTCC-3’ 
Jl215-HindIII-r1 5’-GTGCAAGCTTGGTGCCAGCACCGAACGTTAACGG-3’ 
Jl215-XhoI-f1 5’-GCTCCCTCGAGCAGTCTGGGGCTGAACTGGTGAGG-3’ 
Jl-bstx1-215kf1 5’-GCATCCACAACCATGGAAACCCCAGCGC-3’ 
Jl-Xba1-215kr1 5’-AGCTTCTAGAACTAACACTCTC-3’ 
Jl-Not1-215kr1 5’-ATGGTCTAGAGCGGCCGCTAGAACTAACACTCTCC-3’ 
Jl-MluI-215kr2 5’-ATGGTCTAGAGGATCCACGCGTCTAACACTCTCCCCTG-3’ 
Jl-Xba1-hcr2 5’-AGCTTCTAGACTATTTACCCGGGGACAGG-3’ 
Jlhc-XhoI-f1 5’-CGACCTCGAGCGTCTCCTCAGCTAGC-3’ 
Jlhc-XbaI-r1 5’-GGCCTCTAGAGGATCCTCATTTACCCGGGGACAGGGAGAGG
CTCTTCTGCGTGTAGTGGTTGTGCAGAGC-3’ 
IIB6-BssH2-f1 5’-CTTGGCGCGCACTCCCAGATGCAGCTGGTACAGTCTGG-3’ 
IIB6-Nhe1-r1 5’-GTCTAGCTAGCTGAGGCGACGGTGACCAGGG-3’ 
IIB6-SacI-f1 5’-TATCGAGCTCACGCAGCCACCCTCGGTGTC-3’ 
IIB6-HindIII-r1 5’-TCCCAAGCTTGGTCCCTCCGCCGAACACCC-3’ 
LjIIB6-BssH2-f1 (vλ) 5’-GGACAGGCGCGCACTCCCAGTCTGTGCTGACGCAGCCACC-3’ 
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LjIIB6-Xba-r1 5’-CGAGCTTCTAGAACTATGAACATTCTG-3’ 
Jl-irebamI-f1 5’-TTCCGGATCCGCCCCTCTCCCTCCCCCC-3’ 
Jl-irexbaI-r1 5’-CCTGTCTAGATCACCATGGTTGTGGCCATATTATCATCGTG-3’ 
Jl-SVori-SalI-f1 5’-CTGGGTCGACAATTTAACGCGAATTAATTCTGTG-3’ 
Jl-SVori-EcoR1-r1 5’-CAGCGAATTCAAGGATCTAGGTGAAGATCC-3’ 
Jl-CMV-Xho1-f1 5’-GTCGCTCGAGAATTCACATTGATTATTGAGTAG-3’ 
Jl-EF1a-Xho1-f1 5’-GTCGCTCGAGAATTCAAGCTTCGTGAGGCTCC-3’ 
Jl-polyA-Not1-r1 5’-GGACCGCGGCCGCTCCGCCTCAGAAGCCATAGAGC-3’ 
Jl-SARw-r20 5’-ACTATTTATAAGGTCACGAC-3’ 
IIB6-seq-L 5’-TCTGTTCCCGCCCTCCTCTG-3’ 
Ires-rev-seq1 5’-CTTCGGCCAGTAACGTTAGGG-3’ 
Jlseq-EF215k1 5’-CTTCCATTTCAGGTGTCGTG-3’ 
Jlseq-EF215k2 5’-GGATCTGGAACCGATTTCAC-3’ 
Jlseq-EF215k3 5’-CAGGACAGCAAGGACAGCAC-3’  
Jlseq-Hcmv1 5’-CTAACTAGAGAACCCACTGC-3’ 
Jlseq-Hcmv2  5’-CTCCAAGAGCACCTCTGGGG-3’ 
Jlseq-Hcmv3  5’-CGTCAGTCTTCCTCTTCCCC-3’ 
Jlseq-Hcmv4  5’-CCATCTCCAAAGCCAAAGGG-3’ 
Jl-ireseq1 5’-GGCTCTGCACAACCACTACA-3’ 
Jl-ireseq2 5’-TAGCGACCCTTTGCAGGCAG-3’ 
5.1.11 Plasmids 
pCMV/myc/ER Invitrogen, La Jolla, CA 
pEF/myc/cyto Invitrogen, La Jolla, CA 
pcDNA4/TO Invitrogen, La Jolla, CA 
pIRES-GFP Clontech, Palo Alto, CA 
pCS-venus (Nagai, Ibata et al. 2002) 
pAc-K-CH3 (Liang, Dübel et al. 2001) 
pEPI-1 (Piechaczek, Fetzer et al. 1999) 
pOPE-101-215 Dübel et al., 1993 
pOPE-101-IIB6 In lab (Toleikis dessertation) 
5.2 Methods 
5.2.1 Sterilization  
All experiment water, liquid solution, medium were autoclaved according to standard procedure 
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(Sambrook et al., 2001). Heat-sensitive solutions such as antibiotics, glucose were filter-sterilized 
with 0.20μm filter. 
Glassware was sterilized for 3 h at 180°C. 
5.2.2 Cell culture and storage 
5.2.2.1 E. coli culture and storage  
Transformed E. coli was cultivated overnight on LB plates with appropriate antibiotics at 37°C. 
Liquid culture was inoculated from a single colony and incubated in LB medium containing 
appropriate antibiotics at 37°C with 250 rpm overnight shaking. Freshly grown bacterial 
suspension was adjusted to 15-20% final concentration of sterile glycerol and stored at -80°C. 
5.2.2.2 Mammalian cell culture and storage 
Mammalian cells were seeded in tissue culture plate in appropriate medium. The cells were 
incubated at 37°C in a thermostatically-controlled incubator in an atmosphere containing 5 %CO2 
and at 96 % humidity. To passage adherent cell lines, the cells were washed with PBS and 
incubated with trypsine-EDTA until the cells detached from the bottom of the cell culture plate. 
The cells were pelleted by centrifugation at 1200 rpm for 5 min. The supernatant was discarded 
and the cells were resuspended in culture medium and seeded at the appropriate density. For 
long-term storage, the cell lines were harvested as described above, resuspended in 10 % 
DMSO in relevant culture medium supplement with 20% heat-inactivated FBS for 
cryo-preservation in 2 mL polypropylene cryo-tubes. To allow a slow and gradual freezing, the 
tubes were stored at -80°C in a container for 1-2 days, then, the tubes were transferred to liquid 
nitrogen.  
5.2.3 DNA cloning 
5.2.3.1 Plasmid DNA preparation from E. coli cells 
For minprep plasmid DNA, an alkaline-lysis method (Sambrook & Russel, 2001) or GFX micro 
prep kit were used according to standard procedure or manufacture instructions. Midipreps 
plasmid DNA was prepared using the Sigma high performance Midi Plasmid Purification Kit. 
Plasmid DNA concentration was determined by absorption measurement with 260/280nm in a 
spectrophotometer in a quartz cuvette or compared the intensity of ethidium bromide stained 
linerized DNA bands on a 1% agarose gel with the intensity of defined standards. 
5.2.3.2 DNA electrophoresis 
An agarose gel of 0.8-1.2% was prepared by boiling agarose in 1 x TAE buffer and pouring it into 
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gel-making models till it cooled down to around 60-70°C. Ethidium bromide was directly added 
into the gel with final concentration 100 ng/mL. DNA samples were mixed with 6 x DNA loading 
buffer. DNA samples together with a DNA marker (1 Kb or 100 bp) were separated at 10 V/cm for 
30-60 min depending on the DNA molecular weight and the length of the gel in 1 x TAE buffer. 
The DNA bands separated in the gel were visualizd by 312 nm UV light and pictures were taken 
with a Gel Jet Imager (INTAS, Goettingen) connected to a video printer. 
5.2.3.3 Digestion of DNA by restriction endonucleases 
DNA samples (200 ng – 1 μg) were digested by restriction endonucleases using corresponding 
reaction buffers. Enzyme, DNA, buffer and reaction time varied depending on the specific 
requirements (generally, 37°C from 1 h to overnight). In the case where it was necessary to treat 
the same DNA sample with different enzymes, the digestion was carried out first in a buffer with 
low salt concentration or the buffer compatible to different enzymes. 
5.2.3.4 PCR 
Polymerase chain reaction (PCR) was accomplished with Taq polymerase (Combizyme), 
according to manufacturer protocols. Colony PCR was accomplished with RedTaq polymerase 
(Sigma, steinheim). The oligonucleotide primers were synthesized by MWG Biotech (Ebersberg) 
or Biomers.net (Ulm, Germany). 0,5 pmol oligonucleotide primer were used in a reaction volume 
of 50 μL. The PCR reaction was performed at PTC-200 DNA Engine Thermal Cycler (MJ 
Research). The PCR reaction complex was firstly predenatured at 94°C for 1 min, then followed 
by the cycle reaction, the reaction condition were as follow: denature for 0,5-1 min, annealing 
temperature 55-60°C for 0,5-1 min, extension 72°C for 1 min / kb, 30 cycles. 
5.2.3.5 DNA isolation from agarose gels 
Restricted DNA fragments were separated on 0.8% - 1% argrose gel by electrophoresis. The 
appropriate DNA bands were cut out under UV light. The DNA purification was carried out using 
GFX PCR DNA and Gel purification kit according to the supplier’s manual instructions. 
5.2.3.6 Precipitation of DNA 
2.5 volumes of ethanol and 1/10 volume of 3.0 M NaAc (pH 5.5) were added into the DNA 
solution, mixed 2-3 times, kept at –20°C for 30 min and centrifuged for 10 min at 12000 rpm. The 
supernatant was gently discarded and the pellet was washed with 70% ethanol, followed by 
centrifugation at 12000 rpm for 5 min. The DNA pellet was air dried and dissolved in sterile 
ddH2O.  
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5.2.3.7 Dephosphorylation of digested DNA 
After the digestion with corresponding restriction enzymes, the vector fragment was 
dephosphorylated using calf intestine alkaline phosphatase (CIAP) to remove the phosphate 
group at the 5’-end, which prevent religation of the vector. The reaction mixture was incubated 
around 30-45 min at 37ºC. Dephosphorylation was only performed when the vector plasmid was 
digest by only one restriction enzyme or by two enzymes producing compatible end. The 
dephosphorylation process was omitted, if the two restriction enzymes produced incompatible 
termini.  
5.2.3.8 DNA ligation 
DNA ligation was carried out using T4 DNA ligase (Promega) at 16ºC overnight or room 
temperature for 2-3 hours, in a volume of 10 μL. The concentration of vector and insert DNA was 
measured on the basis of DNA marker. Around 50ng vector was used in one ligation reaction. 
The ratio of vector to insert was 1:3 to 1:5 for sticky and blunt end ligation.  
5.2.3.9 Transformation of E. coli 
Standard procedures of heat shock and electroporation transformation were used (Sambrook et 
al. 2001). Electroporation was performed with Gene-Pulser(Bio-Rad) using electrocompetent 
XL1-Blue cells (Stratagene, La Jolla, USA). Heat shock transformation was performed using 
DH5α (Invitrogen, Leek, Nethelands ) chemical competent cells, prepared according to standard 
procedure (Sambrook et al, 2001). 
5.2.4 Plasmid construction 
All plasmids were constructed using standard E.coli cloning methods as described (Sambrook et 
al. 2001) (Fig 10 A, B). pSL1, a monocistronic expression vector for IgG κ chain was constructed 
based on the vector backbone of pCMV/myc/ER (Invitrogen, La Jolla, CA) through the following 
modifications. First, a human vκ3 leader sequence and a κ constant region were PCR amplified 
from pAc-k-CH3 (Liang, Dübel et al. 2001) by using synthetic oligonucleotides, introducing a NcoI 
restriction site at the 5’ terminus, BamHI and XbaI restriction sites at the 3’ terminus of the 
constant region after the stop codon. The NcoI/XbaI fragment with the vκ3 leader sequence and 
the human κ constant region were then inserted into the NcoI and XbaI sites of pCMV/myc/ER. 
For the construction of the IgG1 heavy chain expression vector pSH1, a human IgG1 constant 
region was PCR amplified from pAc-k-CH3 and cloned into pCMV/myc/ER via XhoI and XbaI with 
a BamHI site introduced at the 3’ terminus of the constant region after the stop codon. The 
variable region genes of a mouse anti-Drosophila RNA polymerase II scFv („215“) (Liu, Song et al. 
1999) were cloned between BssHII/NheI (VH) and SacI/HindIII (VL) of monocistronic IgG1 
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expression vectors. The CMV promoter of pSL1 and pSH1 was replaced by the EF1-α promoter, 
to get the monocistronic expression vectors pSL2 and pSH2. The EF1-α promoter was released 
as an EcoRI and NcoI fragment from pEF/myc/cyto (Invitrogen, La Jolla, CA).  
For the construction of the yellow fluresence protein gene (YFP) expression plasmid pCMV-YFP, 
a modified YFP (Venus) was released from pCS-venus (Nagai, Ibata et al. 2002) via NcoI and 
XbaI sites and was cloned into pCMV/myc/ER between the NcoI and XbaI sites. For the 
construction of the bicistronic expression vectors pDH and pDL, the EMCV-IRES element (nt 260 
to nt 848) fragment was PCR amplified from pIRES-GFP (ClonTech, Palo Alto, CA). The 
BamHI/XbaI fragment of IRES was inserted into pSL and pSH between BamHI and XbaI sites to 
get pSL-IRES and pSH-IRES plasmids. The two plasmids were digested with NcoI resulting in 
LC-IRES and HC-IRES fragments. These fragments were ligated to NcoI digested pSH1, pSL1, 
pSH2, pSL2 and pCMV-YFP respectively, to get bicistronic IgG expression plasmids pDH1, pDL1, 
pDH2 and pDL2 with HC or LC as first cistron, and CMV or EF1-α as promoter. The bicistronic 
expression plasmids pDHIY and pDLIY with human/mouse IgG light chian or heavy chain as first 
cistron and YFP as second cistron were obtained accordingly. The bicistronic expression 
plasmids with YFP as first cistron were constructed by PCR amplifying IRES-light chain and 
IRES-heavy chain fragments from pDH1 and pDL1, and insertion into pCMV-YFP via XhoI and 
XbaI to obtain the bicistronic expression plasmids pDYIH and pDYIL. The tricistronic expression 
plasmid pTLIY was constructed by using BamHI to prepare the IRES-heavy chain fragment from 
pDL1, which was inserted into pDLIY at the BamHI site. All the constructions were confirmed by 
sequencing, the IRES fragment used in this study was a variant with one C deletion between 
base 270 and 280 and a A345G mutation. 
5.2.5 Genomic DNA preparation from mammalian cells 
Cells from a confluent 24-, 12- or a 6- well plate were harvested and washed with PBS, 500μl 
“Modified Bradleys” solution (10 mM Tris/HCl, pH 7.5, 2 mM EDTA, 10 mM NaCl, 0.5 % SDS, 
50-100μg/mL Proteinase K) was added to each well. After a short incubation, the viscous solution 
was transferred in a 1,5 mL Eppendorf tube and incubated at 55°C overnight. The solution was 
cooled at R.T., slowly 1 mL of 100% ethanol 75 mM NaAc was added and the solution was 
incubated for 2 hours at R.T. to precipitate the DNA. The DNA was pelleted by centrifugation at 
R.T. at 5000 rpm for 5 min and the supernatant was discarded carefully. Subsequently the pellet 
was washed with 0.5 mL 70% ethanol and this solution was kept at R.T. for 30 min followed by 
centrifugation. Washing was repeated once and the pellet was air-dried. The DNA was resolved 
in 20-30 μL ddH2O. 
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5.2.6 Protein samples analysis  
5.2.6.1 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
The SDS-PAGE gel consisted of a separating gel topped by a stacking gel. The separating gel 
was casted between the glass plates using Bio-Rad Mini Protean II equipment and overlayed by 
isopropanol. After gel polymerisation, the isopropnol was removed and the gel chamber was filled 
with stacking gel and a comb was inserted. The protein samples were diluted to appropriate 
concentrations, mixed with 5 x Laemmli sample buffer (for non-reducing gel, using sample buffer 
without beta-mercaptoethanol) heated at 95ºC for 5-10 min and the samples were loaded onto 
the gel. Run gels under constant current, 20 mA per mini Gel, at room temperature in 
1xSDS-PAGE running buffer.  
Table 3 Components for preparation of SDS-PAGE 
 Stacking Gels Separating Gels 
 4% 6,% 10% 12% 
Distilled H2O 1,0 mL 2.1 mL 1,6 mL 1,3 mL 
1.5 M Tris-HCl, pH 8.8  1 mL 1 mL 1 mL 
0.5 M Tris-HCl, pH 6.8 0,20 mL    
10% (w/v) SDS 15 µL 40 µL 40 µL 40 µL 
Acrylamide/Bis-acrylamide 
(30%/0.8% w/v) 0.26 mL 0,8 mL 1.3 mL 1,6 mL 
10% (w/v) APS 15 µL 40 µL 40 µL 40 µL 
TEMED 2 µL 2 µL 2 µL 2 µL 
Total monomer 1,5 mL 4 mL 4 mL 4 mL 
5.2.6.2 Coomassie blue staining 
The gel was placed in at least 10-15 volumes of Coomasie Blue staining solution for 1-2 hours. 
The dye solution was rocked gently to distribute evenly over the gel. At the end of the staining, 
the gels were washed with several changes of water. The gels were moved into a solution of 7% 
acetic acid for at least 1 hour. If the background is still deeply stained, the gel was moved to fresh 
7% acetic acid as often as necessary. The gels were placed into containers filled with 7% acetic 
acid as a final fixative and were photographed or scanned for analysis.  
5.2.6.3 Preparation of Cell extracts  
The cells were washed with pre chilled PBS, centrifuged at 1200 rpm for 5 min and lysed with 200 
µL lysis buffer (10 mM Tris pH 7.6, 150 mM NaCl 5 mM EDTA, 1% Nonidet P-40, Protease 
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inhibitors were added before using, 1 mM PMSF, Aprotinin 5 µg/mL, Leupeptin 5 µg/mL, 
Pepstatin 5 µg/mL), incubated on ice for 30 min and centrifuged at 4°C12000 rpm for 10 min. The 
supernatant was collected into a fresh 1,5 mLeppendorf centrifuge tube and stored at –20°C, the 
pellet was discarded. 
5.2.6.4 Western-blot 
SDS-PAGE separated protein samples were transferred to a PVDF membrane through a 
Bio-Rad semi-dry transfer cell, under stable volt 20v (0,75mA per mini Gel) for 45 min. The 
membrane was blocked with 2% skim milk powder-PBS R.T. for 30 min. After washing with PBS, 
the membrane was incubated in 2% skim milk powder-PBS with appropriate diluted primary 
antibody R.T. for 1-2 hours. After washing with PBS-T for 3x5 min, the membrane was incubated 
with appropriate diluted AP conjugated secondary antibody at R.T. for 1-2 hours. After 3x5 min 
washing with PBS-T, the membrane was briefly rinsed with distilled water and developed in 
BCIP/NBT solution for about 20min.  
5.2.6.5 Sample preparation for protein N-terminal sequencing 
The purified IgG protein samples were diluted to about 100-200 μg/mL, 5 x Laemmli sample 
buffer was added and heated at 95ºC for 5-10 min and 10 μL of the samples (about 1-2μg protein) 
were separated on 10% SDS-PAGE under a constant current of 20 mA per mini gel for 50min. 
The gel was rinsed briefly in blotting buffer to wash away excess Tris/glycine/SDS 
electrophoresis buffer (TGS). Then, the separated protein samples were transferred to PVDF 
membrane through a semi-dry transfer cell using freshly prepared transfer buffer for 30-45 min. 
After blotting, the gel was subsequently stained with Coomassie Blue to check the effectiveness 
of transfer. The membrane was briefly washed with Milli-Q water and stained with Coomassie 
Blue till the blot appeared clearly. The membrane was rinsed with Milli-Q water to remove excess 
stain and dried. The desired bands were excised and stored in a microcentrifuge tube at -20°C for 
sequence analysis.  
5.2.7 Transient transfection 
HEK 293T cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) high glucose (4,5 
g/L), 8% fetal calf serum (FCS) 1% antibiotics. CHO-K1 cells were cultivated in DMEM/Ham F12 
supplemented with 8% fetal calf serum (FCS). Cells were grown in 6-well or 24-well flat bottom 
tissue culture plate (Greiner bio-one Corp.). The transfection of plasmids was performed using 
the HEKFectin for HEK 293T and the Lipofectamine 2000 reagents in OPTIMEM1 medium 
according to manual instruction. 48 hours after transfection, antibody expression levels in the 
supernatant were measured by ELISA, reporter florescence gene expression levels were 
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measured by direct readout of the fluorescence protein intensity by TECAN GENios and/or 
FACS.  
5.2.8 Establishment of stable cell lines 
5.2.8.1 Titrating G418 (Kill Curves)  
CHO-K1 culture medium was prepared in 24-well plate, 0,5 mL/well, containing G418 in 0, 500, 
1000, 1500, 2000, 2500 µg/mL respectively in triplicate. CHO-K1 cells were split to the 24-well 
plate at about 50000 cells/well in 0,5 mL medium. The final concentration of G418 was 0, 250, 
500, 750, 1000 and 1250 µg/mL respectively. The cells were incubated at 37°C, 5% CO2 and cell 
growth was observed everyday till the cells were dead.  
5.2.8.2 Cell counting using Hemacytometer 
The cells were tripsinized and pipetted up and down for several times to make cells in single cell 
suspension. A 100μl aliquot was mixed with an equal amount of Trypan Blue. The cover lip was 
placed squarely above the grid of the hemacytometer with a good stick. A small amount of the 
cells and trypan blue mixture about 15-20 μL was added to each side of the grid, so that it flows 
under the covers lip to cover the grid. The cell counter was watched under the microscope and 
the cells were counted in the area upon the grid. The total volume above the grid is 0.0001 mL. 
The blue cells are dead ones, and the bright whiter coloured cells are alive. The total number of 
cells alive and the total number of cells dead were counted in each of the two grids. The cell 
density and total cell amount were calculated. 
5.2.8.3 Screening of stably transfected CHO-K1 clone 
Cells were seeded in 6-well plates at 500000 cells per well and allowed to attach overnight. The 
gene of interest was transfected using lipfectamine 2000 according to the manufacturer’s 
instructions. The supernatant was harvested from each transfected well 48 hours after 
transfection, pre-warmed medium containing G418 500 µg/mL was added. Mock-transfected 
cells were set as control. Antibody concentration in the harvested supernatant from transfected 
cells was measured using ELISA to determine if the transfection was successful. Cell growth was 
observed every 2-3 days and fresh medium with selection drug was changed when it was 
necessary. When the cells in the control wells were all dead, the transfected cells were trypsized 
and counted using a hemacytometer. Cells were diluted to 10,000 cells/mL. 96-well plates were 
prepared with 100 µL fresh medium each well containing 500 µg/mL G418. The cells were 
dispensed to the wells of the first line (8 wells), 100 µL per well, about 1000cells per well. A 
two-time serial dilution was made in the same row from line 1 to 3. Then 1 mL cell solution was 
diluted into 9 mL fresh medium, the cells density would be about 1000 cells/mL. 0,3 mL of the 
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diluted cells solution, about 300 cells, was diluted into 30 mL pre-warmed medium containing 500 
µg/mL G418 and dispensed into the three 96-well plates at 100 µL/well. In the end, there would 
be one cell in 200 µL medium per well. Cell growth was observed, when the medium in the first 
three lines was changed to yellow, the antibody concentration in the supernatant of the first 3 
lines was measured to monitor protein expression. Tiny colonies could be found in the other wells, 
and the wells with only one small colony were marked. About 50-60 mono-colonies could usually 
be found in all the three plates. Cell growth was observed, when the wells containing colonies 
turned to yellow (about at day 21), culture supernatants were harvested and antibody 
concentration was measured using ELISA to screen for positive clones. 
5.2.9 Analysis of the expression levels of YFP reporter gene  
5.2.9.1 Measurement of fluorescence expression using the TECAN GENios 
The expression of yellow florescence protein (YFP) was screened using a TECAN GENios at 
excitation wavelength 485 nm, emission wavelength 535nm, number of flashes 3, lag time 0 μs, 
integration time 20 μs. Multiple reads 12x12 for 6-well plate and 5x5 for 24-well plates was 
performed with the same gain value set in one measurement. Cells transfected with only 
Lipofectamine 2000 reagents were set as background control in every plate.  
5.2.9.2 Flow cytometry  
For analysis of the expression YFP in mammalian cells, all experiments were analyzed using a 
fluorescence activated cell sorter (FACS) analyzer (FACS, Becton Dickinson, San Jose, CA). 
Excitation wavelength was 488 nm and a 530/30 nm bandpass emission filter was used. Forward 
and side scatter was used to establish a collection gate through which dead cells and debris were 
excluded. Between 10000 and 50000 events were collected using list-mode format for each 
experiment. Data were acquired and analyzed using CellQuestTM Pro or with WinMDI 2.8. 
5.2.10 Affinity chromatography purification of IgG1  
About 1 L of culture medium was collected from one antibody expressing CHO-K1 clone or from 
transiently transfected HEK 293T cells. IIB6 human anti-MUC1 IgG1 was purified on a 1-mL 
HiTrap Protein-A-Sepharose column (Amersham, Uppsula, Sweden). The column was 
equilibrated with 20 CV (column volumes) washing buffer, (20 mM sodium phosphate, pH7,0) 
which had been filtered (0.20 µm). The filtered samples were loaded on the column at a flow rate 
of 1 mL/min. The column was washed with washing buffer thoroughly. The antibodies were then 
eluted with 12,5 mM citric acid, pH2,7, 1 mL fractions were collected into tubes containing 50 µL 
1M Tris-HCl pH8,0. Relevant fractions were pooled after checking by SDS-PAGE and dialyzed 
against PBS using dialysis cassettes.  
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5.2.11 Determination of protein concentration 
5.2.11.1 Human IgG capture sandwich ELISA 
Falcon 96-well microtiter plates were coated with 100 µL goat anti-human IgG polyvalent 
antibody (Sigma) (1 µg/well) in 50 mM NaHCO3, pH 9,6 and incubated at 4°C overnight. 100 µL 
FCS was added for blocking at 37°C for 1 hour. The plate was washed with PBS-T for 3 times. A 
standard antibody dilution series was prepared in triplicates at 100 µL per well. 100 µL 
supernatants of transfected cells at different dilutions in PBS-FCS were loaded into the microtiter 
plate in triplcates. Incubated at 37°C for 1 hour. After washing 3 times with PBS-T, 100 µL 
horseradish peroxidase conjugated goat anti-human IgG γ chain specific antibody (Sigma, 
1:10.000 in 50%FCS-PBS) was added and Incubated at 37°C for 1 hour. After washing 3 times 
with PBS-T, 100 µL TMB peroxidase substrates (Dimethylformamide and hydrogen peroxide) 
was added and developed at R.T. for about 30 min (time course depends on colour developing). 
The reaction was stopped by adding 100 µL 1N H2SO4. Absorbance at 450 nm (reference 620 
nm) was read with Sunrise TECAN ELISA reader. For each well, the mean absorbance of the 
buffer wells was subtracted from the mean absorbance of the sample wells to calculate a net 
absorbance value. A standard curve was produced using dilutions of the IgG preparation with 
known concentration.  
5.2.11.2 Bradford Assay 
The TECAN GENios machine was turned on to allow the bulb to warm up (approx. 10 min. before 
use). 5x Bradford Reagent (BioRad) was diluted 4:1 with water. Protein standards were prepared 
in triplicate (10 µL per well) and plated in a 96-well microtitre plate. Column 1 was left as blank, 
plating was started from column 2. The samples was prepared in triplicates (10 µL per well), 
samples should be in the range of the standard curve (0-1 mg/mL for BSA). Samples were diluted 
serially. 200 µL of diluted Bradford reagent was added to each well and incubated for 5 minutes. 
The O.D. was read under excitation light through a 595 nm filter. Standard curve was graphed 
and the samples concentration was determined according to the standards. 
5.2.12 Analytical gel filtration 
Size exclusion chromatography was done on a calibrated Superdex 200 10/300 GL column 
(Amersham, Uppsala Sweden) with an ÄKTA Prime system (Amersham, Uppsala Sweden) at a 
flow rate of 1 mL/min in PBS at pH 7.2.  A LMW gel filtration calibration kit (Amersham, Uppsala 
Sweden) was used to calibrate the column according to supplier’s instructions. The apparent 
molecular mass of IgG was estimated relative to the calibration proteins. 250 µL of purified IgG 
was injected. 
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5.2.13 IgG characterization 
5.2.13.1 Peptide ELISA 
Nunc Maxi microtiter plates were coated with 100 µL streptavidin 2 µg/mL in 0.05 M carbonate 
buffer (pH 9.6) per well and incubated at 4°C overnight. The plate was blocked with 2% BSA/PBS 
at room temperature for 1 hour. 100 µL of the biotinylated peptide solutions into the plate was 
dispensed into the plate and incubated at 4°C overnight (alternatively, peptide can also be diluted 
in coating buffer and coated to Nunc Maxi microtiter plates directly without pre-coated 
streptavidin). After washing 3 times with PBS-T, 100 µL of the samples (appropriately diluted in 
blocking buffer) was added to each well of the plate containing the captured peptides. It was 
incubated at R.T. for 1-2 hrs. After washing 3 times, secondary antibody was added in 
appropriately dilution, incubate at R.T. for 1-2 hours. After washing 3 times, horseradish 
peroxidase conjugated detection antibody was added (appropriately diluted in blocking buffer) 
and incubated at R.T. 1-1,5 hours. The plate was washed 3 times with PBS-T. 100 µL TMB 
peroxidase substrates (Dimethylformamide and hydrogen peroxide) were added and developed 
at R.T. for about 30 min (depending on color developing). The reaction was stopped by adding 
100 µL1N H2SO4. Absorbance at 450 nm (reference 620 nm) was read with Sunrise TECAN 
ELISA reader. For each well, the mean absorbance of the background wells was subtracted from 
the mean absorbance of the wells coated with peptide to calculate a net absorbance value.  
5.2.13.2 FACS analysis of IIB6 IgG binding to cells 
T47D cells were gently scraped from a 10 cm petri dish and collected to a 15 mL falcon centrifuge 
tube. Jurkat cells were used as negative control. Cells were washed one time with staining buffer 
(1xPBS/BSA1%, 5 mM EDTA) and centrifuged at 1200 rpm for 5 min at 4°C. The cell pellet was 
resuspended with staining buffer and aliquoted at 105 cells in 100µL washing buffer to each tube. 
Purified IgG, scFv at different dilutions in 1x PBS/BSA 1% were added and incubated on ice for 
30 min. The cells were washed with 10 mL staining buffer 2-3 times and spun down at 4°C at 
1200 rpm for 5 minutes, supernatant was discarded gently. The secondary antibodies at 
appropriate dilution were added and incubated on ice for 30 min. After washing 2-3 times, the 
cells were stained with fluorescence-conjugated antibody at appropriate dilution, incubated on ice 
for 30 mins. After washing 2-3 times, the cell pellet was resuspended in 400 µL staining buffer 
and kept on ice, till FACS analysis. For live/dead discrimination, propidium iodide (PI) solution 
was added.  
5.2.13.3 Surface plasmon resonance 
The binding affinity analysis of IIB6 IgG to the synthetic MUC1 peptide was performed using 
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surface plasmon resonance (BIAcore X). Binding curves and kinetic parameters were obtained 
as follows: the MUC1 16-mer biotin conjugated (NH2-APDT(GalNAC)RPAPGSTAPPAC-COOH) 
was captured by flowing (20 ng/mL, at 30 μL/min for 2 min) them over a streptavidin chip. 120 
μg/mL BSA was injected to block the unspecific binding (flow rate 30 μl/min for 2 min). 
Subsequently, IIB6 IgG was injected (0,06−6 μM, flow rate 30 μL/min for 1.5 min, dissociate 
about 5 min). The MUC1 peptide surface was regenerated by pulse injection of 0,5% SDS before 
each injection of IgG samples. The curves were analysed with a global fit 1:1 binding algorithm 
with drifting baseline. 
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6.1 General abbreviations 
°C Degree centigrade 
µg Microgramm 
µL Microliter 
µM Micromolar 
A Adenine 
AA  Amino acid 
Ab Antibody 
Amp Ampicillin 
AP  Alkaline phosphatase 
APS  Ammonium-persulphate 
AT CC American Type Culture Collection 
ATP  Adenosin-triphosphate 
BCIP  5-Brom-4-Chlor-3-Indolylphosphate-p-Toluidinsa 
BE Boundary element 
BHK Baby Hamster Kidney 
bp Base pair 
BSA Bovine serum albumin 
C Cytosine 
cDNA Complementary DNA 
CDR Complementary determining region 
CHO Chinese hamster ovary 
Cre Causes recombination (Cre-Recombinase) 
DMEM Dulbecco’s modified Eagle Medium 
DMSO Dimethyl sulphoxide 
DNA Deoxy-ribonucleic acid 
dNTP Desoxyribonukleosidtriphosphat 
DTT Dithiothreitol 
E. coli Escherichia coli 
EDTA Ethylendiamine-tetra-acetic acid 
EF1-α Elongation factor 1-a 
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ELISA Enzyme-Linked Immunosorbent Assay 
ES Embryonic Stem cell 
F Wild type FRT site 
F3 Mutated FRT Site 
Fab antigenbindendes Fragment 
FACS Fluorescence Activated Cell Sorting 
FBS Fetal bovine serum 
Fc Crystallizable fragment 
FITC Fluorescein isothiocyanate 
Flp Flippase recombinase 
Flpe Enhanced flippase recombinase 
FR Framework region 
FRT Flippase recombinase recognition target sequence 
g Gramm 
G Guanine 
G418 Aminoglycoside-2’-deoxystreptine (Gentamycin-derivative) 
Ganc ganciclovir 
GFP Green Fluorescent Protein 
h Hour 
HAMA Human anti-mouse antibody 
hCMV Human cytomegalovirus 
HRP Horseradish peroxidase 
hygtk Hygromycin and thymidine kinase fusion gene 
Ig Immunoglobulin 
IRES Internal ribosome entry site 
kbp 1000 base pairs 
kDa Kilo-Dalton 
kV Kilovolt 
LB Luria Bertani 
LCR Locus control region 
loxP Locus of crossing over of P1 (target sequence for the Cre recombinase) 
M Molar 
mA Milliampere 
mAb monoclonal Antibody 
MAR Matrix attachment region 
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mg Milligramm 
min Minute 
mL Milliliter 
mM Millimolar 
mRNA Messenger RNA 
MUC1 Mucin 1 
NBT p-Nitrotetrazoliumbluechloride 
NC Negative control 
neo Neomycin-phosphotransferase gene 
nm Nanometer 
NP40 Nonidet P40 
nt Nucleotide 
ori origin of replication 
PAGE Polyacrylamide gel electrophoresis 
PBS Phosphate buffered saline 
PBS-T Phosphate buffered saline-tween 
PCR Polymerase chain reaction 
POD Peroxidase 
RNA Ribonucleic acid 
rpm Rotations per minute 
RT Room temperature 
S/MAR Scaffold/matrix attach region  
SAR scaffold attachment region 
scFv Single chain variable fragment  
SDS Sodium dodecyl sulfate 
SRP Surface plasmon resonance 
SV40 Simian Virus 40 
T Thymine 
TAE Tris-Acetat-EDTA-buffer 
TE Tris-EDTA-buffer 
TEMED N, N, N´, N´-Tetramethylendiamine  
Tk thymidine kinase 
Tris Tris-(hydroxymethyl)-aminomethan 
U Unit 
UCOEs Ubiquitous chromatin opening elements  
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v/v Volume percent 
VH Variable region of antibody heavy chain 
VL Variable region of antibody light chain 
VNTR Variable number of tandem repeats 
YFP Yellow Fluorescent Protein 
6.2 Amino acid 
Nonpolar   
Ala A Alanine 
Leu L Leucine 
Val V Valine 
Ile I Isoleucine 
Pro P Proline 
Met M Methionine 
Phe F Phenylalanine 
Trp W Tryptophan 
Polar, uncharged   
Gly G Glycine 
Ser S Serine 
Thr T Threonine 
Asn N Asparagine 
Gln Q Glutamine 
Acidic   
Asp D Aspartic acid 
Glu E Glutamic acid 
Cys C Cysteine 
Tyr Y Tyrosine 
Basic   
Lys K Lysine 
Arg R Arginine 
His H Histidine 
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